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Abstract 
Despite being biocompatible and with optimum mechanical 
properties for application as a bone replacement material, titanium (Ti) 
lacks osteoinductive capacity, i.e. it supports new bone growth on its 
surface but does not foster its formation. This may lead to implant failure 
due to poor osseointegration. Together with infection, this is in fact the 
main cause of failure of orthopedic and dental implants. Therefore, this 
thesis explores the possibility to convert Ti surface into a bioactive 
substrate, which is actively capable of influencing cell fate in vitro and 
enhance implant osteointegration in vivo. 
To install such bioactivity, surface chemical functionalization was 
chosen. Two families of extracellular matrix (ECM)-inspired integrin-
binding biomolecules were tested. Integrins are the major cell surface 
receptor, thus addressing these receptors could be beneficial to tune cell 
response to the surface. One type of biomolecule tested is a double-
branched peptidic ligand that allows for the simultaneous presentation of  
the cell-adhesive RGD (Arg-Gly-Asp) motif and the synergic PHSRN (Pro-
His-Ser-Arg-Asn) motif, which synergizes the RGD-mediated binding to 
integrin α5β1. Alternatively, non peptidic integrin-selective ligands were 
tested as surface coating molecules. These highly stable ligands were 
designed to be selective for either integrins α5β1 or αvβ3. The role of both 
of these receptor subtypes in several bone biology events is currently 
matter of discussion in literature. Grafting of the ligands on Ti was either 
carried out via physisorption or chemical anchoring. Silanization was used 
to create a covalent bond between the synthetic molecules and the metallic 
oxide. Two cell types were used for the in vitro testing of the 
functionalization system: human osteoblast -like cells (SaOS-2) and 
mesenchymal stem cells. The testing of different combinations of 
biomolecule, grafting technique and cell type is the subject of the four full -
papers reported in the thesis. Two of these papers also include the in vivo 
study of the effect of the chemical functionalization in an animal model. 
The thesis also includes a work focused on the merging of two 
surface modification techniques, namely chemical functionalization and 
topographical modification, to create a multifunctional Ti substrate that 
simultaneously addresses the problem of infection and poor 
osseointegration. 
Overall, the collection of works presented in the thesis offer a 
comprehensive view on how chemical functionalization with ECM-
inspired ligands can act as a powerful tool to tune cell behavior and, 
ultimately, guide the biological response at the peri-implant site. 
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Introduction 
Since its introduction in the late 60’, the concept of biomaterials has 
expanded considerably, including an increasing number of devices and 
systems. The first definition of the Consensus Conference on Definitions in 
Biomaterials Science of the European Society for Biomaterials in 1987  as 
non viable material used in a medical device, intended to interact with biological 
systems has evidently become obsolete.[1] Nowadays, ranging from 
diseased or damaged tissue-replacement implants to drug delivery 
systems, biomaterial definition needs to embrace a much wider spectrum 
of systems: as recently proposed a biomaterial is a substance that has been 
engineered to take a form which, alone or as part of a complex system, is used to 
direct, by control of interactions with components of living systems, the course of 
any therapeutic or diagnostic procedure, in human or veterinary medicine .[1] 
Clearly, many branches of research have developed, each focusing on 
specific possibilities of innovation in a defined clinical scenario.  
Among them, implantable materials, i.e. located partially or totally beneath 
the epithelial layer of the body, include hard tissue replacement implants, 
i.e. orthopedic and dental implants, whose actual demand is very high and 
Definition 
of biomaterial 
Implants 
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is expected to increase significantly over the next years. According to a 
projection study of primary and revision joint  replacement surgeries from 
2005 to 2030 in the United States, the demands for primary total hip 
arthroplasties and knee arthroplasties are expected to grow by 174% and 
673%, respectively.[2] Despite both joint replacement and dental implants 
are generally successful, failure leading to revision still occurs. Given the 
huge volume of patients that need these procedures, the need to increase 
implant lifespan for an increasing older population, the economic burden 
of revisions, and the limited healthcare resources, implant performance 
improvement would be beneficial.  
With an operative history of over 50 years, orthopedic and dental 
implants have already been the subjects of a plethora of modification, both 
in their shape design and material choice (bulk properties) as well as in 
their physicochemical properties (surface properties), aiming at increasing 
their lifespan and reducing failure rate. Focusing on implant materials, 
modifications of increasing complexity have been developed.  
The starting point to define candidate materials is the requirement of 
biocompatibility, whose foundation has been identified in a mutually 
acceptable and sustained co-existence of biomaterials and tissues .[3] However, 
such concept is extremely dependent on the specific biological 
environment where the material will be implanted and on the knowledge 
and understanding we acquire on it. The time scale over which the 
material is in contact with the body is a crucial factor to consider when 
classifying a biomaterial as biocompatible or not: a specific material can be 
inert at short time scale but generate a toxic reaction if the exposition is 
prolonged. Consequently, biocompatibility is intrinsically a function of 
time and of the implantation site. In fact, biocompatibility definition has 
evolved hand in hand with our knowledge on the human body and its 
interactions with foreign materials. Traditionally, i.e. between 1940 and 
1980, the concept of biocompatibility was linked to a series of negatives, 
Biocompatibility, 
bioinertia and 
bioactivity 
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such as non-toxic, non-immunogenic, non-irritant, etc.[3] Nowadays, these 
features would rather be associated to a so-called bioinert material, i.e. not 
causing cell death, chronic inflammation, or any other impairment of 
cell/body functions. In other words, this category of materials has no active 
role in the healing process, neither hampering nor fostering the 
regeneration of damaged tissues. On the contrary, newer generations of 
implantable biomaterials aim at positively influencing the healing process,  
i.e. they aim at being bioactive. This feature means that a bioactive 
orthopedic implant, for instance, will foster bone formation at the material-
tissue interface and discourage infection, by directly interacting with 
eukaryotic cells and bacteria.  
The overall aim of this thesis was to design and test, both in vitro and 
in vivo, novel bioactive coatings for orthopedic and dental implantable 
materials. Our strategy and the numerous others documented in literature 
to install bioactivity on surfaces will be discussed in the following sections.  
 
1.1 Materials for hard tissue replacement devices 
Hard tissue replacement devices comprise mainly ceramics and 
metals, but also include some polymeric materials (Table 1.1). These 
materials have to be selected and customized to meet the requirements of 
the replaced tissue, both in their structural bulk properties and in their 
interaction with the body, mainly governed by surface properties. Apart 
from the biological requirements, materials have to be suited to be 
processed for the specific application. Issues such as sterilization and 
manufacturability are paramount for implantable devices, and have to be 
taken into account when selecting the material. Classification based on 
material category is done for the sake of simplicity, since most biomedical 
devices are composed of metallic, polymeric and/or ceramic parts.  
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Material Application 
Metals 
Cobalt-chromium alloys 
Artificial heart valves, dental prosthesis, orthopedic 
fixation plates, artificial joint components, vascular 
stents 
Stainless steel Orthopedic fixation plates, vascular stents  
Titanium and its alloys 
Artificial heart valves, dental implants, artificial joint 
components, orthopedic screws, pacemaker cases  
Gold or platinum Dental fillings 
Silver-tin-copper alloys Dental amalgams 
Ceramics 
Aluminium oxides 
Orthopedic joint replacement, orthopedic load-bearing 
implants, implant coatings, dental implants  
Zirconium oxides Orthopedic joint replacement, dental implants  
Calcium phosphates 
Orthopedic and dental implant coatings, dental 
implant materials, bone graft substitute materials  
Bioactive glasses 
Orthopedic and dental implant coatings, dental 
implants, facial reconstruction components, bone graft 
substitute materials, bone cements  
Synthetic polymers 
Polyethylene 
(UHMWPE) 
Orthopedic joint implants (acetabular coating), 
syringes 
Polymethylmethacrylate 
Bone cements, intraocular contact lenses, dental 
implants 
Table 1.1. Commonly used metals, ceramics and synthetic polymers in hard-tissue 
replacement applications. Adapted from [4]. 
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1.2 The concept of osseointegration 
When fracture or damage to the bone occurs, natural healing 
mechanisms are activated to regenerate the physiological function of the 
tissue.[5] However, in certain conditions synthetic materials are needed to 
support the body in the recovery of homeostasis. In such cases permanent 
endosseous implants are used to be continuously in contact with bone and 
help it withstand the load.   
The success of this kind of devices is based on an efficient 
osseointegration. As originally defined by Brånemark and Albrektsson at 
the end of the 70s, osseointegration refers to a stable anchorage of the 
implant to bone tissue:[6] they had observed that titanium (Ti) and bone 
could become practically fused and could not be separated without 
fracture. Since such direct bone apposition at the implant surface is 
considered a requisite for success, bone-implant contact (BIC), i.e. the 
percentage of the implant surface in contact with bone on a microscopic 
level, is often used as a parameter to assess the degree of osseointegration 
of a tested implant. 
Rather than only indicating the fixation between the synthetic material and 
the tissue, the term osseointegration can also be used to indicate the whole 
process that generates this fused interface.[7] In fact, several steps lead to 
the formation of this interface.  
 
I. Contact with blood and formation of the fibrin clot.  Starting from 
the fracture, either caused by trauma or surgery, the first tissue that 
comes into contact with the implant is blood. Therefore, wound-
healing mediators arrive to the site, including platelets. The 
inflammatory process starts at this point: platelets adsorb on the 
implant within seconds and activate (or degranulate), leading to the 
The definition by 
Brånemark and 
Albrektsson 
The 
osseointegration 
process 
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release of growth factors (GFs), fibronectin (FN) and thrombin, 
which fosters the conversion of fibrinogen into fibrin.  The 
tridimensional fibrin clot acts as a mechanical and biochemical 
substrate for cells: cell-adhesive proteins (FN, vitronectin (VN), von 
Willebrand factor, etc.) and GFs (transforming growth factor beta 
(TGF-β), vascular endothelial growth factor (VEGF), among others), 
which stimulate both angiogenesis and osteogenesis.  Angiogenesis, 
i.e. the generation of new blood vessels replacing the damaged pre-
existing vessels, is essential to support the formation of new bone, 
i.e. osteogenesis, with a proper vascularization.  
 
II. Acute inflammation. Neutrophils are the first inflammatory cells to 
arrive to the implant site, typically within the first 24 h. By secreting 
inflammatory and chemotactic cytokines, these white blood cells 
recruit monocytes and macrophages. Clearance of necrotic tissues 
and provisional extracellular matrix (ECM) follows cell recruitment: 
macrophages phagocyte necrotic cells and the provisional fibrin 
matrix, while monocytes differentiate into osteoclasts, which resorb 
necrotic bone fragments.  Degradation of the matrix is accompanied 
by liberation of GFs, which act as chemoattractants for fibroblasts 
and mesenchymal stem cells (MSCs). Macroscopically, acute 
inflammation is accompanied by warm and swelling of the tissues 
and pain. 
 
III. Granulation tissue. Fibroblasts initiate the formation of granulation 
tissue. Abundant neovasculature and numerous proliferating MSCs 
characterize this connective tissue. The following steps depend on 
the blood supply and stability of the fracture site. 
 
IV. Ossification. Two distinct scenarios are possible: 
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a. High blood supply and good stabilization (typically at short 
distance from the fracture site of large-gap fractures or in 
small fractures). Recruited MSCs differentiate into 
osteoblasts, which secrete alkaline phosphatase (ALP) and 
osteocalcin. Eventually, woven bone is formed via 
intramembranous ossification. Woven bone matrix is mainly 
constituted by type III collagen, with interfibrillar 
mineralization. The structure of this bone is completely 
unorganized and can easily bridge the implant surface and 
the host bone.  
b. Low blood supply and poor stabilization (central areas of 
large-gap fractures). Hypoxic conditions, caused by the 
scarcity of vasculature, drive the differentiation of MSCs to 
chondrocytes, which produce cartilage, and chemoattract 
endothelial cells. These cells form tubular assemblies and 
start bridging the existing blood network. Recruited MSCs 
mainly come from the cambium layer of the periosteum and 
the endosteum. Together with cartilage, newly-formed 
fibrotic tissue forms the so-called soft callus, mainly 
composed by type II collagen, which is gradually invaded by 
new capillaries. This soft fibrocartilage acts as a scaffold for 
the formation of bone tissue via endochondral ossification: 
chondrocytes become hypertrophic and undergo apoptosis, 
secreting calcium. This process generates a calcified cartilage.  
Increasing stabilization and vascularization finally create the 
proper conditions for the deposition of woven bone on the 
fibrocatilage scaffold, i.e. the formation of the hard callus: 
when both ends of the fracture are bridged by the soft callus 
the formation of the new calcified tissue (woven bone) starts, 
proceeding from the periphery to the center of the fracture. 
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V. Remodeling. In the final stage of the fracture healing process 
conversion of woven bone into lamellar bone takes place. 
Osteoclasts resorb the unorganized tissue by attaching to the matrix 
and forming a tight seal area beneath them. Bone resorption 
liberates mineral ions and GFs that stimulate osteoblast -driven 
deposition of new bone. Thus, interplay between osteoblast and 
osteoclasts generate an organized tissue composed by multiple 
lamellae of type I collagen fibers with intrafibrillar mineralization.  
When osteoblasts become surrounded by the newly-formed ECM in 
a so-called lacuna, they become osteocytes, which no longer secrete 
bone matrix. This type of bone cells are sensitive to the loading 
vectors exerted on the bone. Signaling transduction of this 
information to osteoblasts allows the gradual deposition of load-
oriented osteons during the continuous remodeling process that 
takes place in the implant-tissue area. When a load-oriented bone 
structure is formed in contact with the synthetic material, the 
external load is efficiently transferred from the implant to the 
surrounding bone. The formation of this functional interface is the 
essential requisite to obtain the aforementioned osseointegration of 
the endosseous device. 
This process is summarized in figure 1.1. 
As mentioned in the previous section, hard tissue replacement 
devices are modular in design, frequently constituted by several material 
categories. The following section will only concentrate on titanium-based 
metallic materials for joint-replacement or dental devices, given its crucial 
role in those clinical applications.  
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Figure 1.1. Steps of the osseointegration process around implants. (A) 
Erythrocytes (red arrow) accumulate at the implant surface (yellow arrow) 
contributing to the formation of the hemostatic plug, with platelet aggregates 
and fibrin (purple arrow). Within the first hours post implantation, leukocytes 
(white arrow) are responsible of the immune response.  (B) The provisional 
matrix is composed by activated platelets (red arrow) that aggregate within the 
fibrin matrix (purple arrow) and adhere to the implant surface (yellow arrow). 
(C) The fibrin matrix (purple arrow) on an implant surface (yellow arrow) with 
embedded platelets (red arrow). (D) Differentiated osteoblasts (red arrow) 
spread on the implant surface (yellow arrow). (E) Image of an explanted implant. 
Implant osseointegration occurs when the implant surface (yellow arrow) is 
intimately fused with bone (red arrow). The purple arrow points at the interface, 
where a calcified layer with non-fibrillar organic material is observed. Adapted 
from [7]. 
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1.3 Ti-based materials for endosseous implants 
One of the most important criteria to select a material for permanent 
hard-tissue replacement is its mechanical properties: ideally the material 
should efficiently support the surrounding bone in bearing the external 
load for long periods of time. Due to their good mechanical properties, 
metallic materials are selected as the main load-bearing constituent of 
orthopedic and dental devices. Among them, Ti and its alloys are currently 
the most used metals for biomedical applications,[8] mainly due to their 
excellent biocompatibility. They are used in a plethora of applications, 
from dental implants to joint replacement prosthesis (hip, knee, elbow, 
shoulder, etc.) and artificial heart valves. In the following sections their 
bulk and surface properties will be described, focusing on the clinical 
implications of these properties in the context of bone replacement devices.  
 
1.3.1 Bulk properties: the stress-shielding effect 
Hardness, modulus, tensile and fatigue strength are essential bulk 
properties to guarantee the long-term success of the implant.  
Among them, the elastic modulus of the implant material is a very critical 
parameter to tune: it should be as similar as possible to the one of bone, 
which varies between 4  and 30 GPa,[8] depending on the location of the 
bone and of the measuring direction. The elastic modulus of Ti alloys is, 
with few exceptions, one order of magnitude higher than the natural tissue 
modulus (Fig. 1.2), which causes important adverse effects: this 
biomechanical mismatch prevents the stress from being transferred from 
the implant to the bone, leading to the resorption of the bone in the peri-
implant area. Such phenomenon, known as stress shielding effect, most 
probably causes failure due to implant loosening. Together with Ti, 
Ti6Al4V, the most used Ti alloy containing about 6 and 4 wt% of Al and V 
Elastic 
modulus 
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respectively, has excellent corrosion resistance, but still much higher 
modulus than bone. Moreover, clinical concerns have been raised by the 
toxicity of V and its oxides, and the release of Al and V, which has been 
associated to with long-term health problems. Low-modulus Ti alloys have 
been developed to limit the stress shielding effect  and avoid toxic ions. Nb, 
Ta, Mo, Hf,[9] among others, have been proposed as alloying elements to 
lower the elastic modulus and avoid problems related to ion release, since 
none of these ions has been demonstrated to be toxic so far. 
In any case, the elastic modulus of CP Ti and its alloys varies from 110 GPa 
to 55 GPa, which is significantly lower compared to the other two most 
used categories of biomedical metals, i.e. stainless steel (316 L – 210 GPa) 
and CoCr alloys (240 GPa).[8]  
  
Figure 1.2. Elastic modulus of the most common metallic biomaterials. From [8]. 
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1.3.2 Surface properties: a bioinert substrate 
Despite bulk properties define the set of mechanical requisites to 
replace a structural tissue like bone, it is the surface of the implant that 
directly interacts with the host body and eventually determines its long-
term success. In fact, surface properties of the synthetic material can be 
considered decisive on determining the success or failure of the implant , at 
the point that material biocompatibility ultimately depends on them. 
Resistance to corrosion is particularly important in the implantation 
context, where the biological environment can be responsible of 
biodegradation. Consisting in an aqueous environment at 37 °C and an 
almost constant pH of 7.4, the extracellular fluid contains several anions 
(mainly Cl-, HCO3
-, and HPO4
2-) and cations (mainly Na+, Ca2+, Mg2+). The 
concentration of sodium chloride (112-120 mM), for instance, is 
approximately a third of that of sea water. Clearly, the chemical 
mechanisms of metal corrosion in vivo are the same as in a non-biological 
aqueous environment, i.e. oxidation of the metal to its salt and one or more 
cathodic reactions consuming the generated electrons.  
Nonetheless, the biological scenario affects this process mainly in the 
following aspects:[10] 
 Consumption of the products of the anodic or cathodic 
reaction. For instance, proteins binding metallic cations and 
transporting them away from the corrosion site or bacteria 
consumption of the generated hydrogen shift the equilibrium, 
allowing for further dissolution of the metal;  
 Change of pH. Inflammation or bacteria can lower the pH 
locally, changing the stability of the oxide layer; 
 Availability of oxygen. A local depletion of oxygen can cause 
the breakdown of the oxide layer. 
Degradation 
in the body 
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Thus, metals that are subject of corrosion in the biologically environment 
release potentially toxic metallic ions into the body [11]  and can be 
degraded to the point that load is no longer withstood by the prosthetic 
device. As a consequence, a limited range of metals are suitable metals for 
implantation into the harsh conditions of the body. 
The main reason for the success of Ti as implantable material is 
probably its excellent resistance to corrosion, which makes it an ideal 
bioinert material. The reason lies in the stability of its superficial oxide 
(mainly TiO2): given the high solubility of oxygen in Ti, this passivation 
layer spontaneously forms on the metallic surface within seconds of 
exposition to air, and reaches from 1 to 5 nm in thickness.[12] Due to the 
very fast formation, this oxide film is highly amorphous. Since almost no 
grain boundary or other defects are frequent in amorphous oxide layers, Ti 
has a very high resistance to corrosion, which consequently gives it the 
capability of withstanding loads for long periods of time, despite the 
aggressive biological environment.  
 Though Ti intrinsic inertia makes it highly suitable for implantation, 
newer generations of biomaterials are often customized to have a certain 
degree of bioactivity to promote the healing process. In this quest, the 
surface is again the focus of attention, since it is the part of the biomaterial 
that directly comes into contact with the surrounding tissues. The 
following section will describe in detail the methods to install bioactivity 
on the surface of the biomaterial. 
  
A protective 
oxide 
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1.4 Bioactivity 
The first official biomaterials meeting was held in Clemson 
University, South Carolina in 1969, defining biomaterials as synthetic or 
natural materials meant to replace structure and function of body parts. 
Since then, improvement and innovation of this class of materials has been 
gaining more and more importance. The range of natural tissues to be 
replaced has broadened enormously, creating the need for a deeper 
knowledge of the interaction of biomaterials with many different tissues. 
In fact, the actual biggest challenge is not only fitting the material to 
completely different environments and functions in the body, but also 
actively control tissues response, using the biomaterial as an information 
carrier, capable of instructing the body on how to heal in the fastest and 
more efficient way, i.e. creating a bioactive material.  
Thus, efforts are now focusing on how to deposit a specific message on the 
implant and evaluating how efficiently this message is forwarded to its 
surrounding tissues. Though originally referred to the osteoinductive 
capacity of some materials, bioactivity now covers a wide range of 
functions, such as growth factors delivery, stem cell recruitment or 
inflammation and infection control. With one or several of these targets in 
mind, it is evident that a multidisciplinary research must be carried out, 
integrating as much as possible biological, medical, and engineering tools.  
This approach is followed also in the design of bone replacement 
materials, for which, as previously discussed, the process of 
osteointegration is crucial to guarantee the success. Implementation of 
bioactivity on the metallic material can focus on one or more critical steps 
of that process, with the aim of harnessing them towards a fast and 
efficient healing of the injury. To that end, a feasible solution is to apply 
surface modifications to the material: by doing so, bulk properties are 
retained, while the biological response at the implant-tissue interface can 
Bioactive 
substrates 
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be improved or tuned. This concept, also known as functionalization of 
the surface, includes any treatment which adds a biologically functional 
element to the external layer of the biomaterial. Thus, it can aim at 
controlling one or more aspects of the biological response to the implanted 
material, including inflammation, cell behavior and infection.  
When aiming at tuning cell behavior, the rationale behind the 
surface functionalization approach relies on the machinery that cells 
possess to sense with their environment (the ECM). A bidirectional 
communication takes place between cells, which modulate the features of 
the matrix surrounding them, and ECM, which can in turn activate 
signaling pathways. This information exchange is also referred as inside-
out and outside-in signaling, respectively. Numerous transmembrane 
receptors act as mediators of the signaling: integrins, which bind to ECM 
ligands, and GF receptors can work independently or synergically to 
transfer signals between cells and ECM (the reader is referred to section 1.5 
for a complete view on this topic). Importantly, cells not only respond to 
ECM-derived biochemical signals: every property of the ECM influences 
cell response, including its biomechanical properties and its topography. 
The information carried by the ECM can be described to be mainly:  
- Biochemical: the nature of ECM macromolecules is defined by 
their amino acid sequence, charge, hydrophilicity;  
- Physical: the architecture of the environment, which determines 
its mechanical properties of the matrix. 
Though being simplistic, this view sets the baseline for engineering ECM-
mimicking biomaterials that emulate one or more of these aspects.  
 In the context of bone replacement implants, apart from guiding 
cell fate, bioactivity can be implemented also to reduce or avoid infection 
at the peri-implant site. Indeed, development of infection is a huge concern 
in the clinic. In the field of joint replacement devices, inflection is the first 
Signals from 
the ECM 
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leading cause of failure. According to a study aiming at understanding the 
main cause of failure and revision of total knee arthroplasties (TKA), 
infection is the main cause (25.2%) of revision procedures for TKA.[13]  
For the sake of simplicity, surface functionalization strategies can be 
classified into two main categories: modification of either the physical or 
the chemical properties, as represented in figure 1.3. Clearly, combined 
solutions are also reported in literature. Moreover, surface modifications 
rarely involve only changes in chemical or physical properties; in fact, 
chemical treatments usually affect physical properties, and vice versa, 
making classification and comparison between studies very complex.[14] 
Finally, it is important to highlight that the following sections will 
focus only on the functionalization of metallic substrates and disregard the 
use of ceramics and polymers, which are also frequently object of 
bulk/surface modifications. An increasing number of fundamental studies 
on cell-substrate interactions in the literature are involving more compliant 
and realistic substrates such as hydrogel materials or 3D settings. 
Nevertheless, these studies are out of the topic of this thesis and will not 
be covered.     
Types of 
modifications 
Figure 1.3. Schematic representation of the strategies to functionalize the 
surface of biomaterials.  
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1.4.1 Physical modifications 
As previously introduced, cells are sensitive to their environment. 
From the mesoscale, to the microscale and the nanoscale, cells respond to 
the plethora of topographical features of their matrix. The ECM contains a 
milieu of topographical signals, such as the 500 μm villi of the intestinal 
mucosa or the 50-nm thick collagen fibers, which are interpreted by cells to 
guide numerous events, such as adhesion, migration, and 
differentiation.[15,16] Starting with modifications on the micro-scale and 
increasingly developing with nanometric features, topographical 
modifications of the substrate have been reported to be an effective tool to 
regulate cell fate in vitro and tissues responses in vivo. The following 
sections (1.4.1.1 and 1.4.1.2) will resume important contributions on this 
topic. 
Another aspect of the matrix properties is its wettability. Section 
1.4.1.3 will be focused on the effect of modulating this substrate property 
via physical modifications on cells and tissues response.  
 
1.4.1.1 Microtopography  
Pioneering studies in the 90’s revealed the potential use of 
topographical superficial features to control the biological response.[17]  
Analysis of the cellular response to rough surfaces, frequently generated 
via smoothing, grit blasting and/or acid etching,[18] pointed out that cells 
are sensitive to depth, width and orientation of grooves. However, their 
reaction, from elongation in preferential directions to migration and 
differentiation, highly depends on cell type and correlating a clear effect of 
topography on cell behavior has remained elusive.[17] Work by Boyan and 
colleagues demonstrated that MG63 osteoblast-like cells response 
depended on both roughness and chemical composition of Ti and Ti6Al4V: 
In vitro  cellular 
response to 
micrometric 
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in brief, enhanced differentiation was observed on rough materials, where 
cells proliferated less, produced more ALP and OCN, compared to their 
smooth counterparts. Chemical composition of the surface also affected 
ALP production, which was fostered on rough Ti compared to rough 
Ti6Al4V.[19] Similarly, culturing chick embryonic calvarial osteoblasts on 
smooth, rough or porous Ti revealed enhanced differentiation on the non-
smooth substrates.[20]  
Numerous works by Anselme and co-workers extensively analyzed the 
effect of roughness amplitude and order on the attachment of human 
osteoblasts (hOBs) on Ti and Ti alloys, often using a modeling approach. 
Unlike previous studies, lower adhesion, proliferation and focal contact 
formation was observed on rough surfaces compared to smooth ones. 
Thus, a model for cell attachment and proliferation on the basis of surface 
topography was designed for quantitative analysis. Statistical analysis 
revealed that roughness organization parameters (i.e. the fractal 
dimension) affects cell response more than arithmetic roughness (Ra), 
which is used to describe surfaces in most studies.  The main conclusion of 
the modeling study is that the more chaotic the surface (higher fractal 
dimension), the more the cell-substrate contact area decreases.[21] This 
study highlights the fact that only considering the average roughness of a 
surface might not be an accurate indicator to predict cell behavior. Instead, 
other roughness parameters, such as organization parameters, might 
provide more reliable information. 
Parallel to investigations at the cellular level, extensive studies in 
animal models established that micrometric roughness positively affects 
osseointegration. A 1991 in vivo study by Buser and colleagues highlighted 
a positive correlation between surface roughness (around 20 μm) of the 
implant and osseointegration in a minipig model.[22] This study 
introduced an optimal surface treatment, produced using a large-grit (250-
500 μm) sandblasting technique followed by a strong acid-etching with a 
In vivo: 
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mixture of HCl/H2SO4 at elevated temperature, known as SLA (Sand-
blasted, Large grit, Acid etched), which is still popular nowadays.  
Numerous studies followed and confirmed the crucial role of surface 
roughness.[23–26] According to a study by Daugaard et al., microtextured 
Ti implants fostered bone growth and reduced fibrous tissue formation at 
the implant surface, compared to smooth implants in a canine model. [24] 
Interestingly, the theory behind the effect of surface topography at the 
micron-scale on bone-implant contact is not established yet. At least three 
lines of thinking can be mentioned:[14] the biomechanical theory of 
Hansson and Norton,[27] the concept of contact osteogenesis,[28] and a 
cellular signaling-based theory.[29] The first theory, illustrated in figure 
1.4 A, is based on the generation of a mechanical interlocking between 
Models 
Figure 1.4. Three different interpretations of the effect of topography. Norton and 
Hansson describe a biomechanical theory (A), according to which only sufficiently 
big superficial pits can actually resist the interfacial shear by going through bone 
of full mechanical strength (orange with red spots), while smaller pits only go 
through tissues of much reduced strength (layer 1 - much reduced mechanical 
strength immediately adjacent to the implant surface; layer 2 - reduced strength). 
(B) Drawings to show the initiation of distance and contact osteogenesis where 
differentiating osteogenic cells line either the old bone or implant surface 
respectively. (C) Scanning electron microscopy observation of cells cultured on 
polished Ti6Al4V. Cell attachment, proliferation and differentiation are affected 
by topography.  Adapted from [27], [28] and [21], respectively.  
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implant surface pits and bone. In order for pits to efficiently work as 
retention elements with regard to interfacial shear, pit shape and minimum 
dimension were defined via modeling.  
The second line of thinking defines two types of osteogenesis (Fig. 1.4 B): 
distance osteogenesis, where bone growth proceeds from the old bone 
toward the implant, and contact osteogenesis, which implies that bone 
formation starts directly on the implant surface.  Since osteoblast are 
secreting cells with no migrating ability (in synthesizing matrix they 
become trapped into it and become osteocytes), in order for contact 
osteogenesis to take place migration of osteogenic cells to the implant 
surface is required. The ability of the implant surface to retain a stable 
fibrin clot is essential for osteogenic cells to reach the implant surface and 
consequently form bone directly on it (fibrin clot formation has been 
described in section 1.2). This model points at microtopography as the key 
factor to promote such phenomenon, since it increases the available surface 
area for fibrin attachment and provides surface features with which fibrin 
could become entangled.  
The third theory relies on the effect of surface features at the micron-scale 
on cellular behavior (Fig. 1.4 C), which has been mentioned at the 
beginning of this section; roughness is reported to act at the cellular level, 
stimulating differentiation into the osteoblastic phenotype and, therefore, 
bone formation. Nonetheless, the exact cellular mechanisms that underlie 
this effect are not established.  
Recently, studies on surface features as small as cellular receptors are 
focusing on unrevealing them and are covered in the next section. 
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1.4.1.2 Nanotopography  
With the increasing availability of cutting-edge techniques from 
nanotechnology and materials science, the shift from the micro-scale to the 
nano-scale has accelerated. While microtopography is used to influence 
cells in term of cellular and supra-cellular events (cell morphology, tissue 
organization, etc.), the rationale that pulls research towards smaller 
features is that nanotopography affects sub-cellular behavior, such as 
organization of the cell surfaces receptors (Fig. 1.5).[30–32] Numerous 
techniques have been used to generate nanotopographies that aim at 
fostering osseointegration.[14]  
Among the physical methods, compaction of nanoparticles of Ti, Ti6Al4V 
and CoCrMo has been reported to enhance osteoblast adhesion.[33] 
Though generating randomly distibuted nanofeatures, chemical treatments 
are often chosen since they can be readily applied to large surfaces. They 
include acid etching, oxidation, anodization and alkali treatment. In a 
recent work, acid etching (H2SO4/HCl) was combined with sand blasting to 
obtain hierarchical Ti surfaces with micro and nano features (Ra between 
Randomly 
organized 
nanotopography 
Figure 1.5. At the microscale, implant surface microtopography interacts with 
osteoblasts and mesenchymal stem cells at the cellular scale. At the nanoscale, 
cell membrane receptors, such as integrins, can recognize proteins adsorbed on 
the surface, which in turn are modulated by the nanostructures on the surface. 
Adapted from [32]. 
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1.5 and 2.5 nm), which were demonstrated to be simultaneously 
antibacterial and osteogenic.[34] Surface roughness could be easily tuned 
by changing etching time and temperature. Oh et al. used anodization to 
generate TiO2 nanotubes whose diameter (between 30 and 100 nm) could 
dictate cell fate.[35] Bigger nanotubes were associated to increased cell 
elongation and differentiation into the osteoblastic lineage. This led the 
authors to state that increased physical stress induces osteogenic 
differentiation, confirming analogous observations by other authors.[36,37]  
The surface modifications described so far generate features without 
any geometrical control. However, by coupling anodization to porous 
alumina mask [38] or block copolymer template [39], Dalby and co-workers 
could generate highly controlled patterns of TiO2 dots on Ti surfaces, 
which were demonstrated to enhance osteogenesis compared to the flat 
metallic substrate. Clearly, lithographic techniques offer the possibility to 
generate highly controlled nanometric features.[14,40] Nonetheless, they 
are labor intensive and have been mainly tested in vitro, while further 
development is needed in order to readily apply them on implant surfaces. 
In fact, lithography has been mainly applied to model materials, such as 
polymers (polystyrene and polycaprolactone) and glass.[40–42] 
Notably, nanotopography has also been used as a novel bactericidal tool: 
biomimicry of insect wings (the Clanger cicada [43,44] and the dragonfly 
Diplacodes bipunctata [45]) led to the discovery of the bactericidal potential 
of high aspect ratio surface nanometric features: needle-like features kill 
bacteria by imposing high deformational stresses to their membrane, which  
leads to rupture or piercing.[43] Since such intrinsic bactericidal potential 
of the surface is devoid of most limitations of common antibacterial 
coatings, such as silver- or antibiotic-releasing coatings (i.e. the initial 
burst release, the difficulty to control the release profile, the risk of 
developing antibiotic resistance and the limited lifespan [46]), these 
Geometrical 
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nanorough surfaces could be efficiently tested to reduce the incidence of 
infection at the peri-implant site.  
 
1.4.1.3 Wettability  
Water wettability is a surface property whose role in cell-material 
interactions has been investigated in the past twenty years. It has been 
reported to affect several important events in implant osseointegration, 
such as protein adsorption and blood coagulation and clot stability [47–49] 
(the reader is reported to section 1.2 for a complete view of the 
osseointegration process). Specifically, highly hydrophilic surfaces have 
been shown to support faster protein diffusion but less strength of surface-
protein interaction than hydrophobic ones.[47] The fact that hydrophobic 
surfaces may promote higher protein adsorption can be explained 
thermodynamically. A hydrophobic surface in an aqueous solution is 
surrounded by a “shell” of water molecules that interact with each other 
more than with the surface. Such configuration is quite an ordered state, 
with a decreased level of entropy. Protein adsorption would cause the 
disruption of this ordered scenario and therefore be favored energetically 
due a concomitant increase in entropy.[50] On the contrary, on hydrophilic 
surfaces, which would readily generate hydrogen bonds with water 
molecules, a competition exists between proteins and water, making 
protein adsorption thermodynamically unfavorable. It should be noted that 
no unique trend of adsorption as a function of wettability can be identified, 
since this complex phenomenon has been demonstrated to be also 
dependent on substrate curvature and protein size and shape, [51] among 
other factors.  
Nonetheless, blood quickly spreads on hydrophilic substrates, allowing an 
efficient activation of the coagulation cascade on the material,[48] which 
results in fibrin clot stabilization and higher VEGF local concentration.[49] 
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 As previously mentioned, it is often difficult to split the effect of 
single properties, since modifying one of them usually causes concomitant 
alterations of other surface features. The effect of wettability has been 
frequently studied together with the one of topography.  
Numerous recent works focused on chemical modifications to the SLA 
substrate (section 1.4.1.1) leading to increased hydrophilicity (SLActive 
surface).[52–56] Despite the high number of publications based on this 
specific surface, no unique conclusion can be drawn. In vitro, both human 
MSCs (hMSCs) and rat osteoblast-like cells (MG 63) were found to adhere 
and proliferate less on the most hydrophilic substrate, compared to the 
more hydrophobic one.[52,55,56] Cell differentiation into the osteoblastic 
lineage was found to be similar to the SLA surface, only moderately 
improved on the SLActive substrate,[52,55,56] indicating a preponderant 
role for topography, rather than wettability, on the enhancement of 
osteogenesis. Tested in vivo in human models, the SLActive implant was 
found to slightly improve osteogenesis and angiogenesis, compared to the 
SLA one, but to have similar bone resorptive and appositional 
events.[53,54]  
Apart from chemical modifications, other methods have been used to 
generate hydrophilic substrates. UV treatment on rough Ti and CoCr alloy 
was used to study the recovery from aging of metallic samples. [57,58] 
Though the treatment significantly increases wettability,  the conclusion of 
both in vitro and in vivo testing was that the UV treatment mainly restored 
samples bioactivity due to carbon contaminants elimination rather than 
increased wettability. 
 
The SLActive 
surface 
Other 
methods 
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1.4.2 Chemical modifications  
Both organic and inorganic components form bone tissue and 
determine its properties. Often referred to as a mineralized collagen 
matrix, bone tissue is a hierarchical tissue whose primary building blocks 
are collagen type I fibers and plate-like hydroxyapatite (HA) crystals. 
Apart from collagen, a plethora of other organic molecules are also 
contained in bone matrix. In most cases, the strategies of inorganic and 
organic chemical modifications of implant surfaces can be seen as inspired 
by the mimesis of either the mineral or the organic phase of bone, 
respectively. However, many other organic and inorganic surface 
modifications exist that act via other mechanisms, rather than being 
directly bio-inspired from the matrix. The following sections briefly 
introduce the two paths of inorganic and organic modifications. 
 
1.4.2.1 Inorganic modifications  
The idea of coating metallic implants with HA crystals came from the 
observation of the bone bonding ability of calcium phosphate-based 
ceramics.[59] L.L. Hench first demonstrated that a glass with a specific 
composition, known as bioglass, showed direct bone apposition on its 
surface. Materials not promoting such intimate contact with the natural 
tissue would end up encapsulated by a fibrous tissue layer. Since the 
discovery of bioglasses, many other inorganic materials have shown bone-
bonding ability, including HA. The first attempt to transfer this ability to 
the surface of metallic implants was to coat them with HA crystals. 
Plasma-coating was one of the techniques used to generate a superficial 
layer of inorganic material, on which newly deposited HA crystals served 
as a matrix for the bone-forming cells (OBs and MSCs).[60] However, such 
type of coating often suffered from very low stability, related to the weak 
bond created with the metal.[61] 
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To solve this issue, Kokubo and co-workers proposed an alternative 
method to directly generate an apatite layer in intimate contact with the 
metallic substrate.[62,63] By immersing the metal in NaOH solution and 
then applying a heat treatment, a stable layer of amorphous sodium 
titanate is formed (Fig. 1.7). Upon immersion in simulated body fluid (SBF, 
a solution with ion concentration similar to blood plasma), which is 
supersaturated with respect to apatite, ion exchange and electrostatic 
interactions lead to the formation of a calcium titanate and, finally, to the 
formation of a superficial layer of apatite. Unlike deposited coatings, the 
surface obtained with such methodology is highly stable. Moreover, apatite 
deposition was also observed to be efficiently stimulated by such treatment  
in vivo.[64] First demonstrated to be initiated by the NaOH treatment of the 
metal, the same outcome could later be obtained with acid solutions, 
which, instead of generating a negatively charged surface, create a positive 
charge on the surface that triggers an analogous formation of apatite. [63] 
 
 
 
 
Kokubo’s 
method 
Figure 1.7. Scanning electron microscope image of the cross section of Ti after 
NaOH and heat treatment (A); the highlighted thickness is the amorphous 
sodium titanate layer. (B) Nucleation of apatite crystals after immersion in SBF 
for 4 weeks. Adapted from[62] and [63]. 
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1.4.2.2 Organic modifications 
Organic modifications consist in the incorporation of natural, such as 
proteins and peptides, and/or synthetic, i.e. polymers, organic molecules 
on the surface of the implant. In many cases, such modifications mimic cell 
ECM with the aim of creating an instructive microenvironment on the 
surface of the biomaterial. The ECM-inspired approach, based on the use of 
matrix proteins or peptidic sequences is fully covered in the next section.  
Numerous alternative strategies that are not based on the biochemical 
interactions between cells and their matrix have also been described.  Such 
modification can be obtained by diverse techniques, such as self-assembled 
monolayers (SAMs), and can be used for diverse purposes. Though not 
directing interacting with cell surface receptors, these modifications may 
exert an indirect biological effect mediated by changes in surface 
chemistry: alteration of the chemistry affects protein adsorption, which in 
turns influence cell behavior. A very well described example of this 
mechanism is offered by alkanethiol SAMs on gold surfaces. Gold-sulfur 
coordination generates closely packed alkyl chains that can be modified to 
present chemical groups of choice. With this approach SAMs presenting 
terminal -CH3, -OH, -COOH, and -NH2 functionalities were tested and 
demonstrated to modulate FN conformation and, as a consequence, cell 
response.[65] 
Interestingly, organic coatings can be also used to inhibit bacterial 
colonization, a highly important target, given the burden of this 
complication in the premature failure of orthopedic and dental 
implants.[13] The antimicrobial action of surface coatings has been 
described to be via two modes: the bactericidal effect, i.e. the coating 
directly kills bacteria, or the bacteriostatic effect, i.e. hindering of 
microorganisms adhesion on the material.[66]   
Inhibition of 
bacterial 
colonization  
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A direct bactericidal effect can be exerted by certain polymers such as 
chitosan, or by embedding antibacterial agents within the polymeric matrix 
(e.g. chlorhexidine, silver ions or antibiotics). Recently, the use of 
antimicrobial peptides (AMPs) to coat biomaterials has also emerged as a 
powerful strategy to overcome the disadvantages associated to the use of 
antibiotics. The bactericidal action of the coating is mediated by one or 
more of the following mechanisms: inhibition of the synthesis of bacterial 
cell wall (e.g. antibacterial agents such as penicillin or vancomycin), 
disruption of protein synthesis via interference in the mRNA translation 
process (e.g. the antibiotic gentamicin),  permeabilization or disruption of 
cell membrane (e.g. chitosan and several AMPs), or inhibition of the 
transcription and replication of nucleic acids (silver ions are described to 
act via both this  and the aforementioned mechanisms).  
The indirect bacteriostatic effect is commonly obtained via 
poly(ethylene glycol) (PEG)  (or similar polymeric molecules) 
immobilization on biomaterial surfaces. PEG coatings efficiently prevent 
unspecific protein adsorption on Ti [67] and also reduce bacterial adhesion 
and therefore infection occurrence in polymeric clinical devices [68]. 
Though being a promising antibacterial strategy, this hydrophilic coating 
concomitantly inhibits eukaryotic cell attachment, which may be 
detrimental in certain applications. To solve this, cell adhesive peptides 
(such as the peptidic sequence RGD (Arg-Gly-Asp)) are sometimes 
simultaneously anchored to the surface, to provide specific adhesive cues 
for the desired cell type.[69] 
  
PEG 
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1.5 Surface biochemical functionalization 
When the installation of bioactivity on the surface is meant to exert a 
biological effect through biochemical mechanisms, the chemical 
modification can be referred to as biochemical functionalization of the 
biomaterial. Such organic modifications mainly rely on the stimulation of 
specific signaling cascades known to promote the desired response. The 
rationale behind the design of such substrates is that cell response is 
dictated by a plethora of signals embedded in their ECM, which are not 
present in the biomaterial. In order to engineer a biomimetic surface that 
incorporates one or more biochemical cues from the matrix, the way cells 
sense and process the signals from the environment has to be analyzed. 
The following section (1.5.1) will describe the communication machinery of 
cells, deepening in the bone tissue microenvironment. The ligands that can 
interact with cell receptors and the methods to incorporate them on the 
material surface will then be reported in sections 1.5.2 and 1.5.3, 
respectively. 
 
1.5.1 The communication machinery of cells: integrins 
The ECM is a milieu of signaling components that regulate cell 
behavior under precise spatial and temporal control. Including both 
soluble, such as GFs and cytokines, and not soluble molecules, this highly 
complex microenvironment regulates cell recruitment, essential in the 
tissue regeneration process, and dictates proliferation, migration and 
differentiation of residing cells (Fig. 1.8).[70]  Cell-ECM interactions are 
reciprocal, in the sense that cells receive a message from their matrix but 
also remodel it in response to intracellular signals (outside-in and inside-
out signaling). Virtually all cells in the body are embedded in their tissue-
specific matrix: fibroblasts in dermis, chondrocytes in cartilage and 
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osteocytes in bone are completely surrounded by it, while blood cells 
reside in a dynamic environment but are still exposed to ECM proteins, 
such as FN.  
The way cells adhere to the ECM and exchange biochemical signals 
is through cell membrane receptors. The major class of these proteins is 
integrins, a family of 24 heterodimeric transmembrane receptors composed 
by non-covalently bound α and β subunits (Fig. 1.9 A). So far, 18 α and 8 β 
subunits have been identified; each of these subunits consists of a large 
Integrin 
family 
Figure 1.8. Soluble and non soluble components are integrated in the ECM of 
cells and regulate their fate. Adapted from [70]. 
Figure 1.9. (A) Outside-in and inside-out signaling regulate integrin 
conformational changes from the resting bent form to the activated form. (B) 
The focal adhesion is composed by several mediators that bridge the 
transmembrane receptor with the actin cytoskeleton. Adapted from [72] and 
[73]. 
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ectodomain and a typically short noncatalytic cytoplasmic domain, linked 
by a single transmembrane domain. These transmembrane receptors exist 
in two states: a resting state, in which the two subunits are in a bent form 
and do not interact with the matrix, and an activated state, in which α and 
β transmembrane domains are dissociated and binding to ECM proteins is 
favored.[71,72] Upon integrin binding to the ligand, intracellular protein 
aggregates form, known as focal adhesions (FAs). The FA is formed by 
proteins such as talin, vinculin, and α-actinin (Fig. 1.9 B).[73] The first two 
belong to the family of the actin-binding proteins, whose function is 
essentially to connect the dimeric receptor to the actin fiber, mediating 
mechanical coupling and, thus, force transmission across the FA; α-actinin 
is an actin filament cross-linking protein that also transduce intracellular 
forces across the membrane.[74]  
Though integrin-binding proteins are promiscuous, i.e. one protein can 
bind several integrin receptors (Fig. 1.10),[75] it is still matter of discussion 
whether their individual roles are overlapping or not. As reported in a 
commentary paper by one of the pioneers of integrin research, Richard 
Hynes, in 2002 “there is no evidence for overlapping functions or 
Figure 1.10. The integrin receptor family in mammals.  αβ associations are 
organized in subfamilies, according to the ligand specificity. Coloring of α 
subunits reflects the division into evolutionary subfamilies, which is not 
relevant for the present discussion. From [75]. 
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compensation among integrins, but the possibility of some unknown form 
of compensation cannot be eliminated”.[76] In fact, integrin role is often 
investigated via integrin blocking antibodies or genetic modifications 
leading to integrin null organisms, which do not provide any control over 
the possibility of other integrins taking up the role of the blocked or absent 
ones (Hynes even suggests the possibility that antibodies that are 
antagonists of the interaction with a solid substrate might be agonists of 
the signaling cascade activated by the bound receptor). Nevertheless, a 
more recent work already demonstrated that overlapping and 
compensation of functions of integrins α5 and αv do exist in the context of 
remodeling of vasculature during development,[77] testifying that the 
discussion is still open. 
Since integrins act as one of the most important messengers between 
the environment and cells, strategies targeting these receptors have been 
developed to guide the biological response on biomaterials. Surface 
functionalization techniques that rely on this communication system 
consist of the tethering of integrin-binding molecules on the external layer 
of the biomaterial. Importantly, integrin receptors are tissue-specific, 
meaning that only a subset of the 24 heterodimers is highly expressed and 
biologically relevant in the context of a specific tissue. The following 
section focuses on the most biologically important integrins in bone 
biology. 
  
33 
 
1.5.1.1 The integrin system in bone regeneration scenarios: focus on 
osteoblasts and stem cells 
As described in section 1.2, OB and MSC action is crucial in the 
osseointegration process.  The most highly expressed receptors in OBs are 
the β1 subfamily.[78] Moreover, expression of integrins β3 and β5 has also 
been observed.[78–80] Similarly, hMSCs also highly express the β1 
subfamily (more than 80% of cells), along with other integrin 
subtypes.[81,82] A schematic summary of the most expressed subtypes and 
their roles are reported in figure 1.11 and in table 1.2, respectively.  
 
 
 
Figure 1.11. Schematic drawing of bone and endothelial system 
structure and tissue-specific integrin systems. From [79]. 
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Integrin 
subtype 
OB and 
OB-like 
cells 
hMSCs Reported roles 
α1β1 [78,79] [81] Pro-osteogenic pathways, primary adhesion receptor to 
collagen, activation Runx2/Cbfa1, phosphorylation of 
focal adhesion kinase (FAK) [78]. 
αvβ3  [78,79] [81] Vitronectin attachment [81], negative effect on 
proliferation and differentiation [83,84], increased 
proliferation rates [85], major integrin receptor expressed 
by osteoclasts [86], present in nascent focal complexes 
[87], broad lamellipodia and low RhoA activity [88], 
initiation of mechanotransduction [89]. 
α5β1 [78,79] [81] 
 
Fibronectin attachment,[78] expressed during several 
stages of osteogenesis and related to ALP expression [83], 
present in mature FAs [87], associated to well-defined 
stress fibers and high RhoA activity [88], support of high 
matrix forces [89,90]. 
αvβ5  [78] [81] Mediate bone resorption [81]. 
α3β1 [78,79]  Partially mediates adhesion to FN [78]. 
Table 1.2. The main integrin subtypes expressed by OBs, OB-like cells and 
hMSCs. The second and third columns of the table contain the works in which the 
integrin subtype was reported to be expressed by the cell type. The list of 
reported roles is limited to the context of bone biology. 
Apart from the integrins reported in table 1.2, subtypes α2β1 is also 
reported to be expressed in OB and hMSC cultures,[78,81] α4β1 in OBs 
cultures,[79] and α6β1 in hMSC cultures.[81] 
It is worth noting that the roles of single subtype are often 
contrasting. Especially on integrins α5β1 and αvβ3, which are recognized 
as important in bone biology, there seems to be no clear agreement in 
literature: the group of García and co-workers and others authors 
produced several studies attesting the positive role of α5β1 and the 
detrimental one of αvβ3 in osteogenesis induction;[83,91–93] nonetheless 
other authors reported a positive role for the αvβ3 in the progression of 
undifferentiated cells into the osteoblastic lineage.[94–96] 
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1.5.2 Ligands overview: from proteins to short peptidic 
sequences 
90% of bone ECM is composed by collagenous proteins (97% collagen 
type I) and several non-collagenous proteins, as osteocalcin, osteonectin, 
bone sialoproteins, FN and VN.[97] These macromolecules can offer a 
plethora of signals to cells, such as several cell attachment sites via 
different integrins, non-integrin binding domains (such as heparin-binding 
domains), or GF-binding domains. Clearly, their high complexity makes 
them good candidates to coat implant materials and stimulate a positive 
biological response on their surface. Nonetheless, complexity also means a 
lack of tight control over the specific biochemical signal presented to cells: 
the simultaneous presentation of the numerous bioactive domains of the 
full-length molecule hinders the individuation of the main cause of the 
experimental outcome. Along with this, the use of proteins as coating 
molecules bears other drawbacks, such as risk of infection and immune 
response, related to their production in living organisms, low stability to 
degradation (both via enzyme, temperature or pH changes), and 
complexity of manipulation and of production in large amounts. Moreover,  
no control over the exact presentation of motifs is easily achievable, due to 
the sensitivity of protein conformation to surface physicochemical 
properties.[98]   
A lower level of macromolecule complexity and a higher level of 
control can be obtained by engineering protein fragments that only 
encompass the domain of interest. A clear example is offered by FN: this 
ECM protein contains a cell attachment site (CAS) in its type III repeat 
domain (FNIII7-10), where the adhesive sequence RGD (10th III domain) and 
the synergic sequence PHSRN (9th III domain) are found, as shown in 
figure 1.12. The role of the synergy site is to increase the affinity of the 
RGD, which is known to bind several integrin subtypes, for integrin α5β1.  
Full-length 
proteins 
Protein 
fragments 
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To test the role of this subtype in bone biology, García and co-workers 
produced fragments of FN encompassing this region to coat metallic 
implants with the aim of promoting osteogenic differentiation in vitro and 
osseointegration in vivo.[93,99]  
An even less complex alternative to the use of proteins is the selection 
of the bioactive sequence of amino acids of interest. In other words, linear 
peptides can be synthesized to recapitulate only a very specific cue of the 
full-length protein. The RGD peptide, contained in FN and several other 
proteins, is probably the most well-known sequence used to stimulate cell 
adhesion and influence cell proliferation and differentiation on biomaterial 
surface.[98] Such class of ligands has many advantages, including the ease 
of production via peptide synthesis techniques, in large amounts and low 
cost, the absence of infection and immune reaction,  the high stability to pH 
and temperature changes, and the possibility to be anchored to the 
material in a controlled way and at high densities. Importantly though, 
these very simple molecules often lack stability in vivo, due to enzymatic 
degradation, and show a modest stimulation of cell response compared to 
proteins. In some cases, this might be related to the fact that presentation 
of the amino acid sequence may not be optimal to interact with cell 
receptor due to the lack of a secondary structure, or the absence of synergic 
motifs. Moreover, in the case of the RGD sequence, no specificity towards a 
defined integrin subtype or cell type is achievable, since this sequence is 
known to be highly promiscuous.  
Linear 
peptides 
Figure 1.12. FN subunit containing the CAS, where the RGD and PHSRN 
sequences are located.  
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Other approaches to enhance the biological performance of linear 
peptides have been reported:  
 Peptide mixtures: the immobilization of more than one peptide is a 
straightforward and very simple way to provide more than one cue 
on the material surface. The main drawback of this approach is that 
the exact disposition of the peptides on the surface cannot be 
controlled;[100,101] 
 Peptide rational design: multiple peptide sequences can also be 
presented in a chemically-controlled fashion via design of a peptidic 
structure that contains more than one peptide. To do so, linear 
sequences of peptides and branched structures have been used and 
proved effective both in vitro and in vivo;[102]  
 Cyclic peptides: restriction of the conformational freedom of 
peptides is useful to increase stability to enzymatic degradation, 
bioactivity and selectivity;[103,104] 
 Peptidomimetics: these non-peptidic ligands overcome many 
limitations of peptides, such as stability in serum and lack of 
selectivity. They can be designed to reach very high affinity and 
selectivity for one integrin receptor, thus offering the possibility of 
generating integrin-selective surfaces. However, as for cyclic 
molecules, their design is not trivial.[105,106] 
 
1.5.3 Binding of ligands 
1.5.3.1 Physisorption of integrin ligands 
The simplest method to deposit these integrin-binding components 
on the surface of the implantable device is physisorption. This method 
relies on non-covalent interactions between the biomolecule and the 
synthetic material (hydrophobic and electrostatic interactions, van der 
Beyond linear 
peptides 
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Waal forces and hydrogen bonds), which makes it very simple and fast  
(simple impregnation of the material in the molecule solution is often 
enough), with no need for excessive chemical treatments of the surface 
(Fig. 1.13 A).[107] Nonetheless, it evidently lacks stability and control of 
the deposition process. Conformation, orientation, density and 
arrangement of the ligands adsorbed on the surfaces are very difficult to 
control.[65] For instance, this method could lead to adsorption of the 
biomolecule in a conformation that hinders the bioactive motif(s) and 
therefore reduces the efficacy of the coating. Such limitations can deeply 
affect the biological activity of the ligand, leading to modest improvements 
in terms of cellular response.  
 
1.5.3.2 Covalent grafting of integrin ligands 
An alternative method to physisorption is covalent immobilization. 
In this case covalent bonds are formed between the biomolecule and the 
surface, which makes the anchoring much more stable under physiological 
conditions and chemically controlled. Specifically, the orientation of the 
ligand is in this case strictly controlled, since the molecule only binds the 
surface at defined “anchoring” sites. In case the ligand is synthetically 
prepared, the anchor units can be inserted at precise locations to guarantee 
the correct presentation of bioactive sequence to cells.  As a drawback, 
however, these techniques are more complex than physisorption and 
require several chemical steps to be carried out.  
A plethora of techniques to covalently graft ligands to synthetic 
substrates exist, making this method easily adaptable to any substrate. In 
order to get a successful covalent immobilization, the following aspects 
should be taken into account:[7] 
 the attachment site and chemistry must not interfere with the 
functional structure or the active site of the biomolecule;  
General 
guidelines 
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  the distance of the bioactive species from the surface substrate 
should be large enough to allow for the flexible movement and 
self-adjusting that is required for the biomolecules to fulfill the 
desired biological response; 
 the attached biomolecule must not be denatured or inactivated 
at the surface during or following its attachment;  
 the surface density of the immobilized species cannot be too 
high, since over-loading results in overcrowding and reduced 
activity, nor too low, since the deficient loading cannot 
motivate cell response. 
 In the case of metallic implants, the superficial layer where 
molecules should be anchored is in most cases a metallic negatively 
charged oxide. The most common methods to create a covalent bond with 
metallic oxide are the chemical binding of the hydroxyl groups of the 
surface to silanes or phosphonates.  
Figure 1.13 B shows a classical modification by silanization with (3-
aminopropyl)triethoxysilane (APTES), which reacts with the OH groups of 
the surface and polymerizes to forms polysiloxane groups, followed by the 
coupling of the heterobifunctional crosslinker (N-succimidyl- 3-
maleimidopropionate, SMP). Such crosslinker can react with thiol anchor 
groups present in the biomolecule to provide chemically specific binding.  
Such strategy has been used to immobilize cyclic RGD or AMPs to Ti.[108–
110]  
Alternatively, phosphonates also provide binding to metallic oxides 
(Fig. 1.13 C), which is reported to be more stable to hydrolysis than silanol 
groups. The immobilization of bioactive molecules via phosphonic acids 
has been proved efficient on Ti oxide and other metallic oxides.[111,112] 
Silanization 
Chemisorption 
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Recently, a novel chemisorption technique has emerged from the mimesis 
of mussels, which are promiscuously fouling to a wide range of surfaces. 
Analysis of the composition of the adhesive plaque of these animals 
revealed the presence of 3,4-dihydroxy-L-phenylalanine (DOPA) , which 
was found to be a key agent in the formation on covalent and non-covalent 
bonds to inorganic and organic materials.[113] This property was recently 
exploited to bind cyclic RGD and an heparin-binding domain [114] or 
polymer nanoparticles for drug release [115] to titanium. 
 
Figure 1.13. Chemical structures of three immobilization strategies on Ti. 
(A) Poly-L-lysine-g-poly(ethylene glycol) (EG) layer adsorbed 
electrostatically onto a titania surface. The positively charged amino termini 
of the polylysine backbone interact with the negatively charged Ti oxide. 
The water molecules between the polymer chains are indicative of the 
hydration of the brush. Vinylsulfone and one free cysteine (C) of the 
peptide allow establishing a double thiol specific binding between the 
polymeric brush and the bioadhesive RGDC peptide. (B) Silanization of the 
Ti oxide surface by APTES and covalent attachment of a heterobifunctional 
maleimide crosslinker (N-succinimidyl-3-maleimidopropionate) (SMP) 
followed by specific thiol tethering of the cysteine residue of a cyclic RGDfC 
peptide. (C) Self-assembly of four 3-(dietohoxy-phosphoryl)propionic acid 
(DEPPA) on Ti oxide linked together by three branching lysine residues. A 
spacer consisting in three aminohexanoic acids (Ahx) binds to the terminal 
amino of a free lysine of a cyclic RGDfK peptide. Adapted from [7]. 
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Scope of the work 
The present thesis was developed in the context of metals for hard 
tissue replacement implants, with a special focus on superficial 
modifications of Ti that can be applied to support a faster and more 
efficient osseointegration. As discussed previously, there is a growing 
interest in converting biocompatible materials into “smart” information 
carriers, which can deliver specific messages to the surrounding tissues  
and actively guide the healing process. This can be easily done by directly 
modifying the surface, which is responsible for the interactions between 
the synthetic material and the body. Among the methods described in the 
Introduction, the grafting of integrin-binding cues on the surface stands 
out as a straightforward solution to confer such bioactivity.  
Therefore, the overall aim of the thesis is to convert titanium surface 
into a bioactive substrate via chemical functionalization with integrin- 
binding biomolecules, and test the effects of the receptor-selective cues in 
in vitro cell cultures and in an in vivo model. 
 
General 
objective  
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This general goal is further divided into the following specific objectives: 
Objective 1: Anchor to Ti a double branched peptidic platform that 
mimics the integrin-binding site of FN to trigger specific cell 
response in vitro and enhance osseointegration in vivo. This topic is 
covered in Chapter I, which includes the studies of the response of 
OB-like cells (Paper I) and of hMSCs (Paper II) and the study in a 
small animal model (Paper II). 
 
Objective 2: Anchor to Ti two integrin-selective peptidomimetics, 
each of which binds with high affinity one specific integrin subtype 
to trigger integrin-specific cell response in vitro and enhance 
osseointegration in vivo. Chapter II is focused on this objective by 
first introducing the design and biological potential of these 
biomolecules in a review paper (Review Article) and then 
describing their application as coating molecules. The in vitro 
response of OB-like cells and hMSCs is reported in Paper III and 
Annex I, respectively, while the in vivo response in a small animal 
models in Annex I.  
 
Objective 3: The third objective derives from the combination of 
two surface modification strategies, namely a biochemical- and a 
topographical-based one. Nanorough bactericidal Ti surfaces were 
functionalized with the biomolecules described in Objectives 1 and 
2 and the response of hMSCs and the bacteria strain P. aeruginosa 
were studied. This objective, which describes the simple merging of 
two classical modification strategies to generate a multifunctional 
coating, is described in Annex II. 
 
Sub goals 
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The different works described so far are schematically resumed in figure 
2.1. 
 
 
 
Figure 2.1. Schematic representation of the experimental systems studied and the in 
vitro and in vivo assays planned. For each study the surface modification technique is 
indicated in square brackets.  
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Chapter I:  
Functionalizing with a 
peptide-based platform 
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The peptide-based platform consists in a double-branched structure 
that allows for the simultaneous immobilization of two bioactive peptidic 
sequences, as illustrated in figure I.1.  
This molecular design offers a straightforward solution to the limitation of 
linear peptides, which, as discussed in section 1.5.2, are inherently lacking 
multifunctionality and often, as in the case of the RGD sequence, 
selectivity toward a specific cell line or integrin subtype. The possibility to 
include two sequences in the double-branched design brings several 
advantages: notably, by grafting two different sequences ligand 
multifunctionality is readily obtained, the two motifs are always presented 
at a 1:1 ratio, and the distance between the motifs is controlled by the 
molecule’s spacer length. Moreover, these advantages come with a high 
degree of versatility, since the choice of the sequences, their geometrical 
presentation and the anchor can be customized for any application and the 
platform synthesized ad hoc.  
 
This structure is particularly adequate to mimic the CAS of FN, which 
presents the two bioactive motifs RGD and PHSRN at about 35 Å of 
distance,[116] as represented in figure I.2 A. The presence of the synergic 
motif PHSRN makes this attachment site highly affine for integrin subtype 
α5β1,[117] which was reported to be relevant in several events in bone 
The 
biomolecule 
Mimicking FN 
Figure I.1. General structure of the double-branched biomolecule.  
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biology.[91] The double branched structure can easily recapitulate this 
feature in a low molecular weight ligand, by offering the possibility of 
immobilizing both motifs in the same ligand at a controlled distance. To 
mimic the spacing between ligands of FN, four units of aminohexanoic 
acid were chosen for the spacer arms of the molecule (Fig. I .2 B). The 
synthesis of the ligand was carried out using solid-phase peptide 
chemistry by Dr. C. Mas-Moruno at the Department of Materials Science 
and Metallurgical Engineering of the UPC. 
  
The first publication of this chapter is centered on the synthesis of the 
novel ligand and the in vitro testing of the efficacy of the strategy in 
promoting SaOS-2 OB-like cell adhesion, proliferation and differentiation 
into the osteoblastic lineage on Ti. In this proof of concept work, 
physisorption was used to deposit the biomolecule on the metal. 
 
In the second publication of this chapter a covalent binding technique 
(silanization) was used to anchor the ligand to Ti. The in vitro studies were 
Paper I 
Paper II 
Figure I.2. (A) A space-filling model of the FNIII7-10 domain, showing in 
red the two bioactive sequences: the adhesive RGD and the synergic motif 
PHSRN (SYN). Adapted from [116]. (B) The mimetic double branched 
structure presenting RGD and PHSRN.  
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carried out with hMSCs, given their importance in the osseointegration 
process (discussed in section 1.2). Moreover, an in vivo study in a rat model 
is performed to assess the ability of the novel ligand to induce new bone 
growth in an animal model. 
The double branched platform molecule was also used to add cell -
instructive properties to antibacterial nanotopographies that do not 
support efficient cell adhesion. This study, which merges a topography-
based and a chemical-based strategy to generate a multifunctional Ti 
surface, is reported in Annex II. 
   
Annex II 
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Figure S1 
 
 
 
Figure S1. HPLC chromatogram of the peptide-based platform. The analysis was performed using a 
Waters Alliance 2695 chromatography system (Waters), a reversed-phase XBridge BEH130 C-18 column 
(4.6 mm x 100 mm, 3.5 µm) and a photodiode array detector (Waters 2998). The system was run at a flow 
rate of 1.0 mL/min over 8 min at room temperature using water (0.045 % TFA, v/v) and ACN (0.036 % 
TFA, v/v) as solvents (linear gradient from 0 to 40 % of ACN). The platform was eluted at tR = 5.572 
min, and showed a purity > 99 %. 
 
 
 
 
 
 3 
Figure S2 
 
 
 
Figure S2. Adhesion of Saos-2 cells on biofunctionalized surfaces after 4h of incubation. Ti samples 
were functionalized with increasing concentrations of the platform (1, 10, 100 and 200 µM). The number 
of cells attached (cells/cm
2
) was analyzed by means of an LDH assay. Prior to the cell adhesion assays, a 
set of samples were subjected to 3 x 5 min treatments of ultrasonication in distilled water (100 + s). 
Fibronectin (FN) was used as positive control.  The complete experimental details are described in the 
Materials and Methods section. (*) p < 0.1 vs. other conditions. Values are expressed as mean ± standard 
deviation.  
 
 
 4 
Thickness of the peptide layer (platform) attached on the Ti surface   
The thickness of the peptide layer physically adsorbed on Ti samples was calculated from the 
attenuation of the Ti 2p3/2 signal in the XPS spectra according to equations (1) and (2):  
I = I0 exp [-d / (λ sinθ)] (1) 
λ = B(KE)1/2   (2) 
Where I is the intensity of the Ti 2p 3/2 signal in the presence of the platform, I0 the intensity of 
the same signal for control non-coated Ti, d the layer thickness, λ the inelastic mean free path, θ 
the take-off angle (θ = 90), B has a value of 0.087 nm (eV)-1/2 for organic materials, and KE is 
the kinetic energy of the photoemitted electrons of Ti 2p 3/2 [Ref: 1,2]. 
The measured layer thickness obtained for the platform on Ti was of d = 0.50 nm.  
 
References: 
[1] Dettin, M.; Bagno, A.; Gambaretto, R.; Iucci, G.; Conconi, M. T.; Tuccitto, N.; et al. 
Covalent surface modification of titanium oxide with different adhesive peptides: Surface 
characterization and osteoblast-like cell adhesion. J. Biomed. Mater. Res., Part A 2009, 90, 35-
45. 
[2] Briggs, D.; Seah, M. P. Practical Surface Analysis, Vol. 1: Auger and X-ray Photoelectron 
Spectroscopy. Wiley: Chichester, 1990; pp 183. 
 
 
 
 
 5 
Figure S3 
 
 
 
Figure S3. Spreading of Saos-2 cells on surfaces biofunctionalized with fibronectin (FN) after 4h of 
incubation. Images were acquired by fluorescence microscopy and show only staining of actin filaments 
with phalloidin-rodhamine.  
 
 
 
 
 
 
 
 
 6 
Functionalization of Ti with the platform via silanization   
Ti samples were passivated by immersion in a 32.5 % (v/v) solution of HNO3 for 1 h at room 
temperature. After extensive washes with distilled water, ethanol and acetone, the samples were 
dried with nitrogen gas and silanized with (3-aminopropyl)triethoxysilane (APTES) (2 %, v/v) 
(Sigma-Aldrich). The reaction was performed in anhydrous toluene for 1 h at 70 ºC under 
nitrogen atmosphere. After this time, Ti disks were subjected to sonication for 10 min to remove 
non-covalently-bound silanes, and washed with toluene, isopropanol, distilled water, ethanol and 
acetone, and dried with nitrogen. Aminosilanized samples were then further modified by reaction 
with 2 mg/mL of the bifunctional crosslinker 3-maleimidopropionic acid N-hydroxysuccinimide 
ester (SMP) (Alfa Aesar) in DMF for 1 h at room temperature. Samples were finally washed 
with DMF, distilled water, ethanol and acetone, and dried with nitrogen. Finally, the platform 
was dissolved in PBS at pH 6.5 at a 100 µM concentration, and deposited onto Ti samples (100 
µL/disk) overnight at room temperature. After peptide incubation, samples were gently washed 
with PBS and dried with nitrogen.  
 
 
 
 
 
 
 
 
 
 7 
Figure S4 
 
 
 
Figure S4. Adhesion of Saos-2 cells on biofunctionalized surfaces after 4h of incubation. The platform 
was covalently attached to Ti surfaces via silanization. The cell adhesive capacity of the platform was 
compared with control samples: non-coated Ti samples (Ctrol), Ti samples silanized (APTES), Ti 
samples silanized and treated with the crosslinker (SMP). The number of cells attached (cells/cm
2
) was 
analyzed by means of an LDH assay.  The complete experimental details are described in the Materials 
and Methods section. (*) p < 0.05 vs. other conditions. Values are expressed as mean ± standard 
deviation.  
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Table S1. Deconvolutions of XPS spectra, reporting the assignments and percentage of the peaks. 
Modification step Signal BE (eV) / % Assignment (main contributions) 
P 
O 1s 
530.0 / 50.7% TiO2 
531.7 / 49.3% TiOH, physisorbed H2O, organic contaminants 
C 1s 
284.7 / 59.4% -CH2-CH2- 
285.9 / 28.6% -CH2-OH 
288.7 / 12.0% carbonyl groups (C=O)  
HNO3 
O 1s 
530.0 / 64.1% TiO2 
531.7 / 35.9% TiOH, physisorbed H2O, organic contaminants 
C 1s 
284.7 / 63.9% -CH2-CH2- 
285.9 / 29.4% -CH2-OH 
288.7 / 6.7% carbonyl groups (C=O)  
APTES 
O 1s 
529.6 / 57.1% TiO2 
532.0 / 42.9% -Si-O-, TiOH 
C 1s 
284.7 / 58.6 -CH2-CH2- 
285.8 / 35.7% -C-N, -CH2-OH 
287.9 / 5.7% carbonyl groups (C=O) 
SMP 
O 1s 
530.0 / 49.4% TiO2 
532.0 / 50.6% -C=O, -Si-O- 
C 1s 
284.7 / 54.7% -CH2-CH2- 
285.9 / 32.3% -C-N, -CH2-OH 
288.0 / 13.0% amide (-NH-C=O), imide (O=C-N-C=O) 
PTF 
O 1s 
530.0 / 34.3% TiO2 
532.0 / 65.7% -C=O, -OH 
C 1s 
284.7 / 55.0% -CH2-CH2- 
285.9 / 32.7% -C-N, -CH2-OH 
288.0 / 12.3% amide (-NH-C=O) 
N 1s 
399.7 / 84.7% amide (-NH-C=O) 
400.7 / 15.3% -NH3
+
 
PTF (S) 
O 1s 
530.0 / 32.9% TiO2 
532.0 / 67.1% -C=O, -OH 
C 1s 
284.7 / 55.0% -CH2-CH2- 
285.9 / 30.5% -C-N, -CH2-OH 
288.0 / 14.5% amide (-NH-C=O) 
N 1s 
399.7 / 81.8% amide (-NH-C=O) 
400.7 / 18.2% -NH3
+
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Figure S1. (A) Chemical structure of the functionalization system with single (left) or branched 
peptide (PTF, right) (Ahx: aminohexanoic acid; MPA: 3-mercaptopropionic acid). (B) Chemical 
structure of the coating molecules at each modification step: silanization (yellow), addition of the 
crosslinker (blue) and coupling of the biomolecule (purple). 
 
 
Figure S2. Surgical procedure. (A) Press-fit stabilization of the custom-made guide-plate on the rat 
calvaria and initial insertion of the screws. (B) Bone bed preparation for the cylindrical Ti rod 
implantation by LS-reamer. (C) Flat-bottomed bone bed. (D) Stabilization of the custom-made 
polymer cap device by fitting the retention screws. 
  
4 
 
Figure S3. BSA adsorption on the uncoated polished Ti (P) is significantly higher compared to the 
PEGylated Ti (CTRL), the RGD-coated Ti (RGD) and the PTF-coated Ti (PTF), as visible by 
quantifying the fluorescence intensity of the adsorbed FITC-BSA (A). PTF and RGD are also 
PEGylated after coating with the biomolecule. Fluorescence microscopy images of the FITC-BSA on 
Ti are reported in B. * indicates statistical difference (p<0.05) vs. P. 
 
 
 
  
Figure S4. Alizarin Red-positive areas on the functionalized surfaces. Significantly higher 
mineralization is observed on the MIX, PTF and FN in basal medium, while only PTF and FN have 
significantly more deposits compared to the uncoated control (CTRL). * indicates statistical 
difference (p<0.05) vs. CTRL.  
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Chapter II:  
Functionalizing with 
peptidomimetics 
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An interesting alternative to go beyond the use of peptides and 
proteins as coating molecules is given by peptidomimetics. These 
synthetic molecules are generated by mimicking the essential elements of 
natural peptides or proteins in 3D space, retaining the ability to interact with the 
biological target and produce the same biological effect.[1] Such mimicking 
process is performed by re-assembling the critical elements of the natural 
peptide/protein (i.e. the pharmacophore) in a modified scaffold that 
optimizes the interactions with the cell receptor of interest (such as 
integrins), resulting in enhanced biological activity and receptor 
selectivity.[2] Another direct consequence of the introduction of non-
peptide variants in the resulting molecule is high stability against 
proteolysis, which makes these molecules particularly interesting for in 
vivo applications.  
In the field of integrin-binding ligands, such rationale allows for the 
development of ligands that are specific for only one integrin heterodimer. 
Interestingly, such approach can be used to explore the biological role of a 
specific receptor and to create integrin-specific substrates.  
 
In this Chapter the use of two peptidomimetics as Ti coating molecules 
is reported. These ligands illustrate the aforementioned mimesis process: 
derived from the promiscuous RGD sequence, of which they replicate the 
main functional moieties, they are designed to selectively bind either αvβ3 
or α5β1 heterodimers. Design and synthesis of these ligands was 
performed by Dr S. Neubauer and Dr F. Rechenmacher at the group of Prof 
H. Kessler at Technische Universität München (Munich, Germany). 
Optimization of their structure has been performed by carrying out 
docking studies into the crystal structure of the receptor (or a homology 
model of it) and competitive solid-phase integrin binding assays.[3,4] Their 
chemical structures, together with the RGD sequence, are illustrated in 
Peptidomimetic 
definition 
αvβ3- or 
α5β1-selective 
mimetics 
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figure II.1, where the similarities in terms of pharmacophoric groups 
between the natural peptide and its mimetics are highlighted. For instance, 
the 2-amino-4-methoxypyridine group 1 in the αvβ3-selective ligand acts 
as a surrogate of the guanidine of the arginine in RGD. The α5β1-selective 
ligand directly presents a guanidine at the N-terminal of the molecule. The 
carboxyl group 2 is present in all molecules and coordinates a divalent 
metallic cation at the metal-ion-dependent adhesion site (MIDAS) of the 
integrin. In the RGD sequence, the Gly residue ensures an appropriate 
spacing between the basic and acidic moieties, which is crucial to preserve 
the integrin-binding affinity of the molecules. A Gly unit is also present in 
the α5β1-selective peptidomimetic, whereas in the αvβ3 -selective 
peptidomimetic this distance is maintained by the β-homotyrosine group. 
The ORi group present at the C-terminal aromatic residue of both integrin-
selective ligands points out of their respective integrin-binding pockets 
and thus represents an ideal position for further derivatization of the 
ligands for surface coating without affecting their biological activity.[4] 
Moreover, the difference among the two mimetics, which determine the 
selectivity among integrins αvβ3 and α5β1, are also highlighted in the 
structures. One of them is the aminopyridine ring in the αvβ3-selective 
ligand in which a methoxy group is introduced in the para-position (I in 
fig. II.1): Such moiety favors the recognition by the RGD-binding region of 
Figure II.1. Chemical structure of the RGD peptide and the two peptidomimetics.  
The chemical groups of the mimetics which resemble the ones found in RGD are 
circled (1 and 2). As an example, two moieties that give selectivity among the two 
integrin heterodimers are highlighted in gray rectangles (I and II). 
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the αv-subunits, which is bigger and more acidic than the α5 binding 
pocket. Another modification highlighted in the structure in figure II.1 is 
the presence of the mesitylene group in the α5β1-selective ligand (II in fig. 
II.1), which cannot fit into the narrower αvβ3 pocket due to steric clash. 
 
The first publication of this Chapter is a Review Paper, which describes 
the development of the aforementioned and others αvβ3- or α5β1-selective 
molecules. Given the high similarity between these two integrins ( αv:α5, 
53% identity; β3:β1, 55% identity in the integrin headgroup),[5] the design 
of the ligands is not trivial. The reason behind the choice of focusing on 
these two specific integrin subtypes is also discussed in the paper.  
 
The use of these two mimetics as surface coating molecules on Ti is 
reported in the second paper of this Chapter. In this work, the selective 
ligands are anchored covalently to the metallic substrate via organosilane 
chemistry and the response of SaOS-2 OB-like cells is studied.   
 
One of the advantages of working with synthetic ligands is the 
versatility of their structure. Specifically, the anchor moiety of the 
biomolecule can be customized and adapted to the chosen substrate and 
immobilization technique. In the work reported in Annex I two 
immobilization techniques are tested: organosilane chemistry is used for 
the anchoring mimetics with thiol anchor on the surfaces to be tested in 
vitro, while ligands with phosphonic acids as anchors are immobilized via 
chemisorptions for the in vivo study. Attachment, spreading, shape, 
proliferation, and osteogenic differentiation of hMSCs on the 
functionalized Ti substrate are analyzed. The in vivo testing is performed in 
a rat calvarial defect model.  
Review 
Paper 
Paper III 
Annex I 
115 
 
 
The two peptidomimetics ligands, together with the peptidic platform, 
are also used to coat bactericidal nanotopographies that do not support 
efficient cell adhesion. This study, which merges a topography-based and a 
chemical-based strategy to generate a multifunctional Ti surface, is 
reported in Annex II. 
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Table S1. Arithmetic roughness (Ra) of Ti disk surfaces before and after polishing 
treatment, and through the process of functionalization. Values are reported as mean ± 
standard deviation. 
 
 
 
 
 
 
 
 
  
 Ra (nm) 
Ti (not polished) 491.4 ± 75.3 
 Ti (polished) 14.8 ± 1.7 
HNO3 14.3 ± 2.2 
3 
 
Table S2. Binding energy and relative intensity of the deconvolution peaks of the XPS 
spectra of Ti surfaces throughout each step of the functionalization process. 
 
Sample Element BE (eV) 
Relative  
Intensity (%) 
Ti C 1s 284.4 75.00 
  286.0 17.69 
  288.2 7.30 
 O 1s 531.05 57.8 
  532.56 42.2 
APTES C 1s 284.7 64.59 
  285.9 27.92 
  288.0 7.48 
 O 1s 531.1 49.20 
  533.5 50.80 
 N 1s 400.7 66.82 
  402.7 33.18 
Compound 1 C 1s 284.5 47.36 
  285.8 34.54 
  288.1 18.10 
 O 1s 531.2 40.23 
  533.3 59.77 
 N 1s 400.7 22.26 
  402.0 77.74 
Compound 2 C 1s 284.6 51.94 
  285.9 27.90 
  288.1 20.16 
 
O 1s 531.1 39.67 
  533.3 60.33 
 N 1s 401.1 46.91 
  402.0 53.09 
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Figure S1.  
 
 
 
Fig. S1. Fluorescent labeling of peptidomimetics bound to Ti surfaces. Fluorescence 
microscopy images were acquired with a Nikon E600 fluorescence microscope and 
quantification of fluorescence intensity was done using Fiji/Image-J software. 
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Figure S2.  
 
 
Figure S2. Calcification of the ECM visualized by Alizarin Red S staining of calcium 
after 21 days of incubation in osteogenic medium on the (a) uncoated; (b) VN-coated; 
(c) compound 1-coated; and (d) compound 2-coated Ti surfaces. Scale bar: 500 μm.  
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Concluding remarks 
The economic and social burden of the premature failure of joint -
replacement and dental implants is enormous. Given the high number of 
devices implanted every year and the projections of highly increasing need 
in the population, the cost of revision surgeries for the public health 
system and the patients is very high and is expected to increase. Especially 
considering the progressive aging of the population, solutions to ensure 
optimal and lasting osseointegration of the bone-replacement materials 
urge.  
 
One of the most recent strategies to improve the performance of 
implantable devices is to convert biocompatible inert materials into smart 
ones, which not only act as “witnesses” of the healing process, but also 
take an active part into it, by supporting and accelerating the 
reestablishment of homeostasis. To this end, we aimed at mimicking the 
extracellular matrix, since it is a milieu of signals that drive cell fate in toto, 
mainly through integrin receptors. The immobilization of integrin-binding 
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ligands on the surface of the material would readily give its surface the 
capability of guiding cell fate and, in the case of bone replacing implants, 
enhance osseointegration in vivo. Several functionalization systems of 
titanium, based on two families of integrin-binding ligands, were studied 
throughout the thesis and tested both in vitro and in vivo. In both cases, the 
starting point for the design of the ligands was the biomimicry of matrix 
proteins. However, all biomolecules were engineered in different ways t o 
obtain customized properties. 
 
Chapter I was focused on the double branched peptidic platform 
containing the RGD and PHSRN sequences from the integrin-binding site 
of FN. Comparing the linear RGD, the random mix of the motifs and the 
platform, no significant effect was observed on the attachment of both OB-
like cells and hMSCs on Ti, in terms of cell number. These results suggest 
that at short time and in absence of serum, the number of attached cells, 
though significantly higher compared to the uncoated titanium, is not 
affected by the specific ligand immobilized. Nonetheless, the controlled 
presentation of the sequences within the platform did foster cell spreading 
at short time, compared to RGD alone and the randomly distributed 
sequences, both in the case of SaOS-2 and stem cells. Interestingly, an 
aspect that was found to be deeply influenced by the structure of the 
ligand was cell differentiation into the osteoblastic lineage: mineralization, 
of both cell types, and gene expression of MSCs were boosted by the 
presence of the double-branched ligand, which also induces de novo bone 
formation in the in vivo model. 
 
The coating of the metallic substrate with αvβ3- or α5β1-selective 
peptidomimetics was explored in the second Chapter and in Annex I. 
Again, as observed with the platform, both OB-like cells and hMSCs are 
RGD-PHSRN 
platform 
Peptido-
mimetics 
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more prone to adhere on functionalized Ti, but do not discern among the 
specific ligand presented. Nevertheless, MSC shape and differentiation 
potential were sensitive to the integrin-specific substrate. The αvβ3-
selective surfaces promoted a star-like shape of cells, while cells elongated 
more on the α5β1-selective Ti. Importantly, the αvβ3-selective ligand was 
found to promote osteogenic differentiation of stem cells in vitro and 
increased bone growth in vivo, supporting a positive role of this receptor in 
the progression into the osteoblastic lineage.  
 
Overall, the results of this thesis prove that biochemical 
functionalization of implant surfaces is a potent tool to harness cell 
behavior. Though not explored in this thesis, such substrate-mediated 
control of cell fate would be beneficial in several different contexts, from 
the basic research aiming at elucidating the effects of environmental 
signals, such as receptor-activated signaling cascades, to the in vitro 
induction of a specific lineage for tissue engineering applications.  
 
In the field of bone replacement implants, the use of biochemical 
functionalization is sometimes looked at with skepticism. Most 
biomolecules, such as full length proteins, linear peptides and protein 
fragments, would likely suffer from enzymatic degradation into the body, 
which could hamper their efficacy. On the other hand, more stable 
alternatives, namely cyclic peptides and peptidomimetics, require a 
complex molecular design, which necessitates specific expertise and might 
be highly time-consuming. Stable and controlled immobilization on the 
biomaterial can be another important concern: chemoselective strategies 
minimizing the uncertainty on reaction yield are desirable for robust 
application of the coating. Notwithstanding that, the results obtained in 
this thesis demonstrate that such subtle modification of the implantable 
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device with synthetic ligands, which only affects the chemistry of the 
surface and has no effect on the design or bulk properties of the implant, 
has a high potential of guiding cell fate and can be effective in the in vivo 
scenario, despite the aforementioned concerns. Moreover, synthetic ligands 
have important advantages that would facilitate their translation in clinical 
applications: peptidic coating solutions can be used for multiple coatings 
since about 0.3-1.3% of the total amount of peptide in the coating solution 
binds to the surface and coated surfaces have been demonstrated to be 
resistant to several sterilization methods. Though the exact chronology of 
events happening in vivo at the implant surface is not elucidated yet, the 
positive results obtained in this work encourage the further development 
of this versatile and potent strategy, aiming at creating bioactive interfaces 
with increasing control of the surrounding microenvironment. The study 
reported in Annex II offers an example of this versat ility: by grafting the 
receptor-binding ligands to Ti nanostructures, eukaryotic cell response is 
readily tailored, while antibacterial properties of the substrate remain 
unaffected. 
 
The spectrum of application of chemical functionalization is 
potentially huge: functionalization can be static (via surface 
immobilization) or dynamic (e.g. stimuli-responsive release), it can involve 
numerous categories of biomolecules, from adhesive or antimicrobial 
peptides, to growth factors or chemoattractants, and it can be applied to 
many substrates only by tailoring the chemistry of immobilization. All 
these features give biochemical functionalization a degree of specificity (to 
cell-type, tissue or application) that would be difficult to obtain with other 
surface-focused modifications. 
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Annex I 
Paper IV 
Integrin-selective peptidomimetic coating of 
titanium drives stem cell response in vitro and 
enhances bone growth in vivo 
Considered their high activity, selectivity and stability, non-peptidic 
integrin antagonists stand out as promising molecules for surface coating 
applications. Nonetheless, this category of ligands has been seldom used 
for this purpose. Especially in vivo characterization of peptidomimetic-
coated implants is missing. In this work we use two different strategies to 
chemically anchor αvβ3 or α5β1 integrin-selective RGD mimetics to 
titanium, either via terminal thiol or phosphonic acid moieties, and report 
for the first time that surfaces functionalized with integrin-binding 
peptidomimetics tune both in vitro and in vivo biological response. Both 
integrin-specific surfaces promote mesenchymal stem cell adhesion and 
spreading to the same extent as full-length proteins. Moreover, on the 
α5β1-selective surface cells adopted more elongated morphologies and 
increased cell growth rates were observed, while on the αvβ3-selective 
surfaces cells developed a star-like shape and displayed commitment into 
the osteoblastic lineage. In vivo, bone growth in rat calvarial defects was 
increased on implants coated with the αvβ3-selective peptidomimetic 
compared to uncoated and α5β1-functionalized implants. These results 
demonstrate that this molecular chemistry-derived approach could be 
successful to engineer instructive coatings for orthopedic applications.   
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Surface chemical modification of implant materials is a viable strategy to 
address unmet needs of orthopedic and dental implants. Indeed, 
interactions between biomaterials and tissues at the surface level are 
responsible for the most important causes of failure of these devices, such 
as aseptic loosening, infection and fibrous encapsulation.[1] To deal with 
these issues, cell-instructive coatings have been proposed as a solution to 
promote osseointegration by stimulating direct bone deposition on the 
implant.[1–4] Ligands from the extracellular matrix (ECM) of bone have 
been used as a source of inspiration to design numerous peptidic 
ligands[5–8] and protein fragments[2,9] to coat metallic substrates. Many 
examples exist of RGD-containing peptides or fibronectin (FN) fragments 
encompassing the integrin-binding site of the protein tethered to 
Fig 1. Chemical structure of the integrin antagonists, spacers and anchor groups, and schematic 
representation of the functionalization strategy. Peptidomimetics were anchored via thiol group 
for the in vitro assays (R1 spacer and anchor), and directly tethered via phosphonic acid for the 
in vivo study (either R2 or R3 spacers and anchors). 
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biomaterials and tested in vitro.[10–12] Several in vivo studies are also 
reported.[2,3,13,14] On the contrary, non-peptidic integrin antagonists 
have been rarely used for this purpose. Highly active,  subtype selective, 
and with good pharmacokinetic profiles, these ligands hold high potential 
for implementation as surface-coating molecules.[15] While few examples 
of in vitro studies are available in literature,[16–18] in vivo characterization 
of peptidomimetic-coated implants has never been reported.   
Recently, our group proposed the application of peptidomimetic ligands as 
surface-coating molecules to generate either αvβ3 or α5β1 integrin-
selective surfaces.[19,20] Among the integrin family, αvβ3 and α5β1 
subtypes have been identified as important receptors in the adhesion, 
proliferation and differentiation of osteoblasts and mesenchymal stem cells 
(MSCs).[21,22,12] Based on this, addressing these receptors could be 
beneficial to enhance the osseointegration of bone-replacing implants. 
Thus, in this study we explored the chemical anchoring of αvβ3 - or α5β1-
selective RGD mimetics onto titanium (Ti), the most relevant metallic 
material for orthopedic and maxillofacial applications,[23] and evaluated 
the biological effect of these molecules both in vitro and in vivo.  On the 
basis of the biological application, two distinct immobilization methods 
were investigated (Figure 1): i) for the in vitro studies, the two mimetics 
were designed with a mercaptopropionic acid as terminal group and linked 
to the metal via the thiol functionality, through a Michael addition on the 
maleimido-functionalized silane layer; ii) for the in vivo tests, a direct 
binding of the molecules to the superficial layer of Ti dioxide was 
preferred, and therefore the use of phosphonic acids via chemisorption was 
exploited. This method reduces the number of steps and manipulation of 
implant materials and would be more appropriate than silanization in a 
clinical setting. Moreover, the capacity to fine tune the chemical grafting of 
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the peptidomimetics by simply changing the anchoring moiety of the 
synthetic ligands highlights the versatility of our coating strategy.  
Thus, to conduct in vitro cellular studies Ti surfaces were functionalized 
with the peptidomimetics via silanization. This protocol was optimized by 
us in a previous study and characterized by means of contact angle 
measurements, fluorescent labeling and X-ray photoelectron spectroscopy 
(XPS).[20] In vitro studies were focused on the response of human MSCs 
(hMSCs). This choice is due to the crucial role of these multipotent cells in 
the healing process:[24] evidence exists of cell homing to the injured tissue, 
active participation in the reparative events via differentiation into bone-
forming cells, and contribution to the creation of the regenerative 
microenvironment, by secreting bioactive factors.[25]  
By functionalizing Ti with the αvβ3- or α5β1-selective 
peptidomimetics (αvβ3-s or α5β1-s surfaces, respectively) adhesion of 
hMSCs on the substrate was highly increased after 6 h of incubation in 
serum-free conditions (Figure 2a), to the same extent as the full-length 
glycoproteins vitronectin (VN) and FN. No difference was observed 
between the number of cells adhering to the proteins and to the α5β1 -
selective and the αvβ3-selective compounds. Following the same behavior 
as the number of attached cells, hMSCs spread more on all integrin-
binding substrates, compared to the uncoated metal (Figure 2b). 
Nevertheless, cell shape was found to be ligand-dependent (Figures 2c, 2d, 
2e). When no functionalization was done, cells remained small and 
rounded. On VN cells were highly rounded and almost no cytoskeletal 
elongation was observed; the distribution of actin fibers was either parallel 
to the cell boundary or centrifugal, i.e. from the nucleus to cell edges.  
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Fig 2. (a) Cell attachment in serum-free conditions is significantly increased on coated Ti, 
irrespectively of the specific ligand presented. * means p<0.01. (b) Cell projected area after 6 
hours of incubation in serum-free medium is increased by all ligands. Dots represent individual 
cells, the boxes represent the 25th and 75th percentile, the middle line is the median, the 
whiskers are one standard deviation, □ is the average, × correspond to the 99% and 1% of the 
values. * means p<0.01. (c) Immunostaining of actin fibers and nuclei after 6 hours of incubation 
in serum-free medium. Cell shape, number and direction of cytoskeletal elongations depends on 
the ligand anchored to Ti. (d) Values of mean roundness and aspect ratio of cells seeded on the 
functionalized substrates. * means p<0.05 vs. Ti, # means p<0.05 vs. αvβ3-s. (e) Immunostaining 
of actin fibers, vinculin and nuclei after 6 hours of incubation in serum-free medium. 
 167 
 
On the contrary, many cytoskeletal elongations were observed on FN, 
where cells also reached a less rounded morphology; actin fibers in this 
case distributed mostly parallel to cell edges. On both mimetics, hMSCs 
developed elongations. However, these were more numerous on the αvβ3 -
selective mimetic, with no preferential direction, giving a star-like shape. 
On the α5β1-selective ligand cells attained a much more elongated shape, 
with few elongations per cell distributed in one preferential direction. 
Overall, these observations translated in statistically lower values of 
roundness and higher values of aspect ratio on FN and α5β1-s, compared 
to all other conditions (p<0.05). Cell shape has been demonstrated to be a 
regulator of the commitment of MSCs into different lineages;[26–28] 
therefore, the observed differences might reflect in different differentiation 
behavior.  
Response at long term was also ligand-dependent: the number of 
metabolically active cells was higher on all functionalized surfaces, 
compared to uncoated Ti (p<0.01), with FN-coated Ti being the surface 
promoting the highest proliferation among all conditions (p<0.01) (Figure 
3a). The α5β1-selective ligand supported the same proliferation as the full 
length VN at all time points. Proliferation was lower at 3 and 6 days of 
incubation on the αvβ3-selective mimetic, compared to all other coated 
surfaces (p<0.01). To qualitatively observe cell growth on the metallic 
substrate, actin cytoskeleton and nuclei were immunostained after 2 and 4 
days of incubation (Figure 3b). In terms of number of attached cells, 
microscopic observations were coherent with the trend of cell growth 
observed via the proliferation assay (Ti<αbβ3 -s<α5β1-s~VN<FN).  
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However, the spatial distribution of cells after 2 days of incubation was 
strongly affected by the surface-bound ligand: hMSCs formed isolated cell 
clusters on αvβ3-s, α5β1-s and VN, while they distributed homogeneously 
on FN. After 4 days of incubation, this behavior was maintained, and a 
multilayer of cells covering the entire surface was observed on FN-coated 
samples, in accordance with a faster cell growth on these surfaces. Having 
observed higher cell number on the α5β1-selective ligand, than on the 
αvβ3-selective one, these results support a positive role for α5β1 in 
proliferation. We could observe a similar behavior with human osteoblast -
like cells in a previous work.[20] However, hMSCs proliferate significantly 
more on FN at all time points, also in comparison with the α5β1 -slective 
surface. This behavior could stem from the promiscuity of the full length 
glycoprotein, which, apart from having high affinity for integrin α5β1, has 
Fig 3. (a) Alamar blue assay of cell proliferation indicates that cell growth follows this trend: 
FN>VN~α5β1-s>αvβ3-s>Ti, therefore indicating that FN (among proteins) and the α5β1-
selective mimetic (among peptidomimetics) foster the highest value of proliferation. * means 
p<0.01. (b) Immunostaining of actin fibers and nuclei after 2 and 4 days of incubation on the 
substrates; cell growth follows the same trend observed in (a). 
 169 
 
multiple domains that interact with other cell receptors and growth factors, 
as observed in previous works.[29,30] 
Since different proliferation trends and cytoskeletal organization 
were observed on the mimetics, differentiation was expected to vary 
depending on the receptor-selective coating. As previously introduced, 
Kilian et al. characterized the relationship between shape and lineage 
commitment, demonstrating that shapes that fostered increased cell 
contractility promote osteogenesis.[27] Despite their study used FN islands 
to confine cell shape, star-like shape was associated to osteogenesis due to 
increased myosin contractility. In our work no constraint is applied to 
cells, however hMSCs acquired different shapes depending on the integrin 
antagonist anchored to the surface. To investigate the commitment of cells 
to the osteoblastic lineage RT-PCR was used, evaluating gene expression of 
two markers of osteogenic differentiation (Figure 4a). After 7 days of 
incubation in basal medium, the expression of both RUNX2 and OCN is 
increased on the αvβ3-selective mimetic, compared to uncoated Ti. 
Moreover, expression of RUNX2 is the highest among all other 
functionalized substrates. Enhanced levels of RUNX2 were also reported 
for MSCs seeded on self-assembled monolayers encompassing a cyclic 
RGD peptide with high affinity for αvβ3.[12] Overall results suggest a 
more osteoinductive effect of the αvβ3-selective surface, compared to the 
α5β1-selective one, which more efficiently supports proliferation.   
To verify this trend in the in vivo scenario, we tested the 
osteoinductive capacity of mimetic-coated Ti implants in a partial 
thickness calvaria defect of rat. For this study direct binding of phosphonic 
acid groups to Ti oxide was used. This is a simple one-step process; 
however, coupling of these types of anchor groups to the bioactive 
sequence is synthetically more demanding than the incorporation of one 
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terminal thiol group.[31,32] We used XPS to study phosphonate-anchor 
mimetic binding to the metal (Figure 5). Four coating concentrations were 
tested, from 1 μM to 200 μM. Phosphorous (P 2p), only present in traces on 
the uncoated Ti surface, was detected after binding the two mimetics, and 
its atomic percentage increased proportionally to concentration, until 
reaching a plateau at 100 μM, which was chosen as the coating 
concentration. This signal corresponds to the Ti-O-P bond, as reported in 
other studies.[32,33] Moreover, the coating was proved to be stable, since 
neither atomic percentages of Ti and P, nor P 2 p spectrum were  affected 
by the ultrasonication treatment. For the implantation in rats, custom-made 
mimetic-functionalized cylindrical implants (5.5 mm diameter, 5 mm long) 
were inserted in the 5.5 mm defect and covered with rigid polymer caps 
(Figure 4b). After 2 or 4 weeks of implantations, animals were euthanized, 
and tissues were harvested and stained for histological observation with 
hematoxylin and eosin (H&E) stain. Confirming in vitro observations, the 
substrate with high affinity for integrin αvβ3 was more osseoinductive, 
promoting increased new bone growth at the defect site (Figure 4c). Newly 
formed bone showing woven features was visible in contact to the αvβ3 -s 
surface, with osteoblasts aligning on the surface of the bone, while more 
fibrous tissue formed at the interface between the α5β1-s implant and the 
calvaria. Bone formation was also observed in some α5β1 -s samples after 2 
weeks of implantation; however results were more modest in this case and 
not reproducible through all samples. These effects could st em from the 
different biological roles described for these membrane receptors.[17,34,35] 
Previous in vivo studies evaluating Ti or Ti alloy implants coated with 
cyclic RGD, known to have high affinity for integrin αvβ3,[36] also 
reported significant increase in bone formation,[37] less fibrous tissue 
formation surrounding the implant and, therefore, increased implant 
fixation[14,38] in presence of the peptidic coating.  Accelerated bone repair 
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adjacent to the αvβ3-s implants was evident at early time points (2 weeks); 
this result is of relevance because early bone fixation is critical to 
guarantee orthopedic and dental implant success.[39,40] Stimulation of 
α5β1 has been shown to promote bone formation in other studies using FN 
mimics,[2] however a remarkable effect was not observed in our in vivo 
model.  
 
Fig 4. (a) Expression of osteogenic markers on the functionalized substrates. Increased 
expression is observed on the αvβ3-selective mimetic for both genes, compared to Ti. *  
means p<0.05. (b) Implantation scheme: the dashed area represents the area shown in 
the histologies in (c). (c) Representative H&E staining histological images. Scale bar = 
150 μm. The bottom part of the images is the dural side of the calvaria. Increased new 
bone growth (regenerated bone, RB) is observed in presence of the αvβ3-s coated Ti 
implant (the inset shows aligned osteoblasts), while more fibrous tissue (FT) is observed 
adjacent to the α5β1-s coated implant. 
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In conclusion, our work shows the high potential of peptidomimetic 
ligands to generate bioactive surfaces for clinical applications. Both 
immobilizations to Ti via either thiol or phosphonic acid were proved 
efficient, confirming the versatility of the approach: by selecting the proper 
anchor unit, biomolecules suitable for different coating procedures or 
materials can be easily designed. Noteworthy, small, stable, and selective 
ligands could often attain the same cell response as complex full -length 
ECM proteins. We could demonstrate that the αvβ3-selective surface 
fosters hMSCs osteogenesis in vitro and new bone formation in vivo, while 
the α5β1 antagonist more efficiently promoted proliferation of cells in 
vitro. Moreover, mimetics are devoid of immunological response and 
stable to enzymatic cleavage, which makes these custom-made synthetic 
antagonists particularly suitable coating molecules for clinical implantable 
devices. 
  
Fig 5. P 2p spectra (a) and Ti and P atomic percentage (b) of uncoated Ti (Ti) and 
mimetic-functionalized Ti at different coating concentrations (1 μM, 10 μM, 100 μM, 
200 μM) and after an ultrasonication treatment to verify stability (100S). *  means 
p<0.05.  Atomic percentages of Ti and P decrease and increase, respectively, at 
increasing concentrations, reaching a plateau at 100 μM. Neither atomic percentages 
nor P spectra are modified by the ultrasonication treatment, confirming stability of the 
coating. 
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Experimental Section  
Ti surface functionalization. Ti disks were obtained by turning cylindrical CP 
bars (10 mm in diameter, Technalloy S.A., Sant Cugat del Vallès, Spain). Polishing 
with silicon carbide girinding papers (Neuertek S.A., Eibar and Beortek S.A., 
Asua-Erandio, Spain) and with suspension of a lumina particles (1 μm and 0.05 
µm particle size) on cotton clothes was carried out to achieve a smooth mirror -like 
finish of the surface. After ultrasonically rinsing with cyclohexane, isopropanol, 
distilled water, ethanol, and acetone, samples were passivated with 65% (v/v) 
HNO3 for 1 h. Afterwards, disks were silanized by immersion in 2% (v/v) APTES 
(3-(aminopropyl)-triethoxysilane, Sigma-Aldrich, St Louis, MO, USA) in 
anhydrous toluene (Sigma-Aldrich) in agitation at 70 ⁰C for 1 h under nitrogen 
atmosphere. After rinsing samples with toluene, distilled water, ethanol, and 
acetone, a curing of the silane layer was performed at 120 ⁰C for 5 min. To couple 
the crosslinking agent N-succinimidyl-3-maleimidopropionate (SMP) (Alfa Aesar, 
Karlsruhe, Germany), disks were immersed in disks in 7.5 M solution in agitation 
for 1 h at room temperature. For in vitro studies, peptidomimetics with thiol 
anchor were immobilized on Ti surface by dissolving the biomolecules in 
phosphate buffered saline (PBS) at 100 μM and pH  6.5, and then depositing 100 
μL of these solutions overnight on Ti disk surfaces at RT. For in vivo studies 
peptidomimetics with phosphonic acid anchors were directly deposited on Ti  
samples (PBS, 100 μM, overnight, RT). VN and FN (both from Sigma -Aldrich) 
were coated on Ti at 50 μg/mL in PBS at pH 9.5 instead. Uncoated polished Ti 
disks were selected as negative controls (Ti).  
Cell culture. All reagents were purchased from Sigma-Aldrich, unless otherwise 
noted. hMSCs (SCR 108, Merck Millipore) were cultured in Advanced Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% (v/v) fetal bovine 
serum (FBS), 50 U/mL penicillin, 50 μg/mL streptomycin and 1% (w/v) L -
glutamine. Cells were maintained at 37 °C, in a humidified atmosphere containing 
5% (v/v) CO2 and culture medium was changed twice a week. Upon reaching 70 % 
confluence, cells were detached by trypsin-EDTA and subcultured into a new 
flask. Cells at passages between 1 and 4 were used to carry out all the 
experiments. To evaluate cell attachment, hMSCs were plated at 104 cells/mL and 
incubated 37 °C and 5% (v/v) CO2 containing atmosphere. After 6 h of incubation 
in serum-free medium, immunofluorescent staining of cell nuclei and actin fibers 
was performed to count attached cells. To study proli feration of cells on the 
substrates, 6 × 103 cells/mL were plated on samples in serum-free medium and 
incubated as previously explained.  
Cell immunostaining and proliferation.  After plating cells as previously 
described, and removing non-adherent cells by gently washing samples with PBS, 
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hMSCs were fixed with paraformaldehyde (PFA, 4% w/v in PBS) for 20 min, and 
permeabilized with 500 μL/disk of 0.05% (w/v) Triton X -100 in PBS for 20 min. 
The surface was blocked with 1% BSA (w/v) in PBS for 30 min, actin fibers and 
nuclei were stained by incubating with rhodamine-conjugated phalloidin (1:300, 
in Triton 0.05% (w/v) in PBS) for 1 h and with 4’,6-diamidino-2-phenylindole 
(DAPI) (1:1000, in PBS-Glycine 20 mM) for 2 min at RT in the dark, respectively. 
Samples were rinsed three times with PBS-Glycine for 5 min between each step of 
the staining procedure. Ti disks were examined under a fluorescence inverted 
microscope (AF7000, Leica, Germany), and quantification of nuclei and cell 
projected area was done with the Fiji/Image-J package. For the cell proliferation 
assay, 6-hours post seeding, medium was aspired and replaced with complete 
medium. After 3, 6, and 8 days of incubation, cell number was evaluated with the 
Alamar Blue assay (Invitrogen Life Technologies, Merelbeke, Belgium): briefly, 
Alamar Blue-containing medium (10% (v/v)) was added for 1 h, and fluorescence 
of the dye was quantified according to the manufacturer instructions with a 
multimode microplate reader (Infinite M200 PRO, Tecan GroupLtd., Männedorf, 
Switzerland).  
Cell differentiation. Gene expression was evaluated by RT-PCR analysis. 104 
cells/well were plated on metallic disks and cultured for 7 days in basal medium. 
At harvest, cells were lysed and total RNA was extracted using RNeasy® Mini Kit 
(Qiagen, Hilden, Germany), according to manufacturer instructions. Total RNA 
was quantified with NanoDrop ND-1000 spectrophotometer (Thermo Scientific, 
Waltham, MA, USA). 200 ng of RNA were reverse transcripted to cDNA with 
QuantiTect Reverse Transcription Kit (Qiagen). A StepOnePlus Real -Time PCR 
System (Applied Biosystems, Foster City, CA, USA) with QuantiTect SYBR Green 
RT-PCR Kit (Qiagen) and gene-specific primers for runt-related transcription 
factor 2 (RUNX2 – primer sequences: FW: CGGAATGCCTCTGCTGTTAT, RV: 
TGGGGAGGATTTGTGAAGAC) and osteocalcin (OCN - primer sequences: FW: 
ATGAGAGCCCTCACACTCCT, RV: CTTGGACACAAAGGCTGCAC) were used, 
doing a 5 min incubation at 95 °C and 40 amplification cycles (10 sec at 95 °C and 
30 sec at 60 °C), followed by a melt curve. Melting curve analysis was done to 
prove specificity and gene expression was normalized to β -actin (primer 
sequences: FW: AGAGCTACGAGCTGCCTGAC, RV: 
CGTGGATGCCACAGGACT).  
In vivo implantation. To test the ability of the biomolecule coating to induce bone 
growth in vivo a rat partial thickness calvarial defect was used. The protocol of 
housing, care, and experimentation was approved by the Animal Care and Use 
Committee at Dankook University, Republic of Korea. Eighteen 11 week-old, 250-
300 g healthy male Sprague-Dawley rats were used. Animals were acclimatized 
for 7 days before implantation, and each rat was housed in a separate cage under 
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temperature- and humidity-controlled environment, exposed to a 12 h light-dark 
cycle, and had free access to water  and food. Custom-made rod-type Ti implants 
(5.5 mm diameter, 5 mm long) were prepared and functionalized by immersion in 
the mimetics solution. After coating, samples were washed three times in sterile 
MQ water and sterilized by incubating in 70% ethanol for 30 min. Implant 
placement was performed under general anesthesia using an intramuscular 
injection of a mixture of ketamine (80 mg/kg) and xylazine (10 mg/kg). The 
animals were randomly allocated to one of three groups before implantation 
(n=6): Ti as the control group, avb3-selective mimetic-coated Ti, and a5b1-
selective mimetic-coated Ti as study groups. After shaving over the cranial lesion, 
the surgical site was scrubbed with iodine and 70% ethanol, and a linear skin 
incision was made. A full thickness flap was retracted and the calvarial bone was 
exposed. Two 5.5 mm diameter partial thickness calvarial bone defect were 
prepared in each rat on each side of the parietal bone under cooling conditions 
with sterile saline buffer, using a dental handpiece and a 5.5 mm diameter LS -
Reamer (Neobiotech, Seoul, South Korea). The implants were covered by 3D 
printed rigid polymer caps, and the cap and Ti constructs were secured to the 
calvarial bone using fixation screws via its anchoring rings. Rigid polymer caps 
(5.5 mm inner diameter and 5 mm height) were custom-made (Taulman 618 
Nylon, Taulman 3D, Missouri, US) by 3D printing (NP -Mendel, Opencreators, 
South Korea). The subcutaneous tissues and periosteum was sutured with 
absorbable sutures (4-0 Vicryl®, Ethicon, Germany), and the skin was closed with 
non-absorbable suture material (4 -0 Prolene, Ethicon, Germany). The animals 
were monitored daily for possible clinical signs of infection, inflammation, and 
any adverse reaction. After two and four weeks, the animals were euthanized by 
CO2 inhalation and the tissue part of the calvarium surrounding the cap was 
harvested and fixed in 10% neutral buffered formalin for 24 hours at RT. The 
samples were then decalcified with RapidCalTM solution (BBC Chemical Co., 
Stanwood, WA), dehydrated and embedded in paraffin using standard 
procedures. Five serial sections (5 μm) were cut at the central of the defects, and 
the deparaffinized sections were subjected to hematoxylin & eosin (H&E) stain, 
and then imaged using a light microscope.  
Statistical analysis. Statistical comparisons were based on analysis of variance 
(ANOVA) with Tukey post hoc test for pairwise comparisons and non-parametric 
Mann-Whitney test. Results are presented as mean + SEM.  
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Annex II 
Paper V 
Towards the cell-instructive bactericidal 
substrate: exploring the combination of 
nanotopographical and chemical cues on Ti 
surface 
Engineering the interface between biomaterials and tissues is crucial to 
increase implant lifetime and avoid failures and revision surgeries. Ideally, 
permanent devices should enhance attachment and differentiation of stem 
cells, responsible for injured tissue replacement and repair, and 
simultaneously discourage bacterial colonization. To obtain such 
multifunctional surface we propose merging two strategies, topography- 
and chemistry-based. We coated bactericidal titanium (Ti) 
nanotopographies, which are not particularly eukaryotic cell-adhesive, 
with integrin-binding synthetic ligands that could rescue the adhesive 
capacity of the surfaces and instruct mesenchymal stem cell (hMSCs).  
Three different topographies were tested, coated alternatively with an 
αvβ3-selective peptidomimetic, an α5β1-selective peptidomimetic, or a 
RGD/PHSRN double-branched peptidic molecule. The effect of such 
combination of cues on hMSCs was studied. SEM observation revealed 
different cell attachment modes depending on the topography. Increased 
cell area, reduced circularity, more intense and larger focal adhesions were 
detected when the substrate was biomolecule-coated, irrespective of the 
substrate topography. Expression of osteogenic markers was also fostered 
on the αvβ3-selective peptidomimetic-coated substrates. Finally, bacterial 
tests confirmed that topographies remain bactericidal in presence of the 
biomolecules. Such dual physicochemical approach to achieve 
multifunctional surfaces holds great promise for the design of novel cell -
instructive biomaterial surfaces. 
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1. Introduction 
According to a projection study through 2030, the burden of primary 
and revision joint arthroplasties is expected to increase significantly [1]: 
The number of hip replacement primary surgeries will grow by 174% by 
2030 in the United States (from 208,600 in 2005 to 572,000), causing a 
growth for revision surgeries, which are expected to double by year 2026.  
Thus, despite a track record of positive outcomes, orthopedic implant 
failure will be a major clinical concern in the future as we strive to support 
the aging population. To address this problem, the two leading causes of 
implant failure should be taken into consideration: aseptic loosening and 
infection, which account for 18% and 20% of revision of total knee 
arthroplasty, respectively [2]. Though several causes for aseptic loosening 
exist, poor osseointegration is one of them. This highlights the importance 
of investigating on the design of multifunctional orthopedic coatings that 
are simultaneously antibacterial and osseoinductive [3,4]. With a few 
recent exceptions [5,6], most studies focus on either cell-guiding or 
antibacterial properties of the coating, ignoring the possibility of combined 
effects.  
In the past ten years nanotopography has emerged as a potent tool to 
tune the response of human stem cells [7–9] and, more recently, to give 
antibacterial properties to the surface [10–12]. Topographical features of 
the surface at the nanometer scale have been shown to affect adhesion, 
proliferation and differentiation of mesenchymal stem cells, 
osteoprogenitor cells and osteoblasts [9]. Closely-packed hexagonal array 
nanotopography on tantalum has been demonstrated to foster osteogenesis 
and extracellular matrix (ECM) protein deposition of human mesenchymal 
stem cells (hMSCs) [13]. Osteogenic differentiation of hMSCs was also 
observed when cells were cultured on large titania nanotubes (100 nm 
diameter), compared to small nanotubes (30 nm diameter) [14]; this effect 
was ascribed by the authors to the increased cytoskeletal tension, which is 
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known to drive osteogenesis [15,16]. In a previous work we also 
demonstrated that the order of the nanometric features of the surface has a 
role in the induction of osteogenic differentiation [17]. A controlled degree 
of disorder of nanopits on poly(methyl methacrylate) (PMMA) promoted 
osteogenesis in absence of osteogenic soluble supplements, compared to a 
completely random and a fully-ordered substrates [17].  
Following a biomimetic rationale, nanotopographies were also proved 
to be potentially antibacterial. Features similar to those of bactericidal 
insects’ wings (the Clanger cicada (Psaltoda claripennis) [18,19] and the 
dragonfly Diplacodes bipunctata [20]) have been reproduced on the surface 
of artificial materials such as titanium and black silicon [10,20]. Both 
insects’ wings present high aspect ratio surface nanometric features that 
have been demonstrated to be bactericidal. The needle-like features were 
found to effectively kill bacteria by imposing high deformational stresses 
to their membrane (leading to rupture or piercing) [18]. Such intrinsic 
bactericidal properties are particularly interesting for application in 
biomaterial surfaces since they are devoid of the limitations of numerous 
antibacterial coatings, such as silver- or antibiotic-releasing coatings, i.e. 
the initial burst release, which may be even cytotoxic to cells, the difficulty 
to control the release profile, the risk of developing antibiotic resistance 
and the limited lifespan, given the decreasing concentration of the released 
species.[4]  
Despite their potential as antibacterial surfaces, such bio-inspired 
nanotopographies might not be optimal for eukaryotic cell-instructive 
purposes (e.g. osseointegration) and could even lead to a reduction in the 
cell adhesive properties of the surface. A viable solution to such issue is 
chemical functionalization to anchor cell receptor binding molecules on the 
surface. A family of biomolecules derived from the ECM, from the full-
length proteins [21], to protein fragments encompassing the bioactive 
sequence of the protein [22], to small peptidic sequences [23–26], and 
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peptidomimetics ligands [27], have been used to create MSC-instructive 
substrates and thus can potentially be used to rescue the cell-instructive 
capacity of antibacterial nanotopographies. In doing so, multifunctional 
substrates that are simultaneously bactericidal and cell-instructive can be 
envisaged. 
Herein we present a combined approach that merges bio-inspired high 
aspect ratio nanotopographical cues with the chemical grafting of integrin-
binding peptidic ligands to engineer a bactericidal and osseoinductive 
titanium (Ti) surface. The rationale of this design is that biomolecule-
coated metallic nanotopographies can simultaneously be bactericidal, due 
to the insect wing-inspired topography in our case, and cell-instructive, 
thanks to the presentation of cell receptor-binding cues at the surface. Two 
different nanotopographies generated by hydrothermal treatment were 
tested. Three different peptidic ligands were coupled to the topographies 
to verify the combination of topography and low molecular weight 
Figure 1. Chemical structure of the integrin-binding ligands: αvβ3-selective peptidomimetic 
(light blue), α5β1-selective peptidomimetic (dark blue), and RGD/PHSRN platform 
(orange). Phosphonic acid anchors are highlighted in purple and thiol anchor is highlighted 
in red. 
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receptor-binding ligands in supporting hMSC adhesion and differentiation 
and avoiding bacteria colonization. Two families of peptidic ligands were 
used: two integrin-selective peptidomimetics molecules, selective for 
integrin αvβ3 or α5β1 respectively, and a double-branched peptidic ligand 
containing the RGD and PHSRN sequences from fibronectin, recently 
synthesized in our laboratories (Fig. 1) [23,28]. We have previously 
demonstrated that both ligands families stimulate osteoblast-like cell 
attachment, cell spreading and osteogenic differentiation [23,29].  
 
2. Materials and methods 
2.1. Ti substrate preparation 
Ti disks were prepared from a 0.9 mm thick ASTM grade 1 Ti sheet (Ti 
metals Ltd, UK). For the smooth control surfaces (denoted by FLAT), disks 
were polished to a mirror image and ultrasonically cleaned in water and 
ethanol. Nanotopographies were generated by an alkaline hydrothermal 
process, as previously described [10]. In brief, Ti disks were immersed in 1 
M NaOH in a polytetrafluoroethylene (PTFE) lined steel vessel (Acid 
Digestion vessel 4748, Parr Instrument Company, USA) at 240 °C for either 
2 h (denoted by FINE) or 3 h (denoted by COARSE). The vessel was 
removed after each time point from the oven and allowed to cool to room 
temperature (RT). The samples were rinsed in water and ethanol, 
sequentially, and then heat-treated at 300 °C for 1 h. To convert the sodium 
titanate layer generated during the process to TiO2, samples were 
immersed in 0.6 M HCl for 1 h, rinsed in water and ethanol, and finally 
heat treated at 600 °C for 2 h. 
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2.2. Ligand conjugation to the metallic surface 
All samples were preliminarily cleaned with nitric acid (1 h, RT) and 
rinsed with water, ethanol and acetone. Previously synthesized [23,28,30] 
integrin-selective molecules (Fig. 1) were covalently attached to the surface 
by dissolving the molecules in phosphate buffered saline (PBS) at 100 μM, 
and then depositing 100 μL of these solutions overnight on Ti disk surfaces 
at RT. The two integrin-selective peptidomimetics directly binded to Ti 
oxide via the anchoring phosphonate groups. The efficiency and stability of 
this coating method was proved in previous reports [31–33]. The αvβ3-
selective peptidomimetic was labeled V3, while the α5β1-selective one was 
labeled 51. Alternatively, the peptidic RGD/PHSRN platform (labeled as P), 
which has a thiol group as anchoring group, required an extra step of 
silanization. In that case, Ti disks were exposed to silane vapor ((3-
aminopropyl)triethoxysilane, APTES) in a vacuum chamber and kept at 100 
°C for 30 min. Straight after silanization, the crosslinking agent N-
succinimidyl-3-maleimidopropionate (SMP, 7.5 M in N,N-
dimethylformamide (DMF)) (Alfa Aesar, Karlsruhe, Germany) was coupled 
by immersing the disks in DMF under agitation for 1 h at RT and rinsing 
with DMF, distilled water, ethanol and acetone. The peptidic platform was 
then anchored following the same protocol as the peptidomimetics 
molecules (100 μL drop, 100 μM in 6.5 pH PBS). The dissolving buffer for 
the platform is slightly acidic to prevent disulfide bond formation. 
Detailed characterization of this protocol has been reported elsewhere  [29]. 
Experimental conditions were labeled according to the topography and the 
peptidic ligand grafted, such that FINE-V3 corresponds to the FINE 
topography coated with the αvβ3-selective peptidomimetic. All reagents 
were from Sigma-Aldrich, unless otherwise stated. 
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2.3. Surface topography characterization 
Ti topographies were mounted onto stubs and sputter coated with gold 
(high resolution sputter coater, Agar Scientific) for analysis on a Zeiss 
Sigma FE-SEM microscope. Height profile of the topographies was 
obtained by white light interferometric microscopy (Wyko NT9300 Optical 
Profiler, Veeco Instruments, New York, NY, USA) in vertical scanning 
interferometry mode. Data analysis was performed with Wyko Vision 4.10 
software (Veeco Instruments). 
2.4. Cell culture 
hMSCs (Promocell, Germany) were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 
200 mM L-glutamine (Invitrogen), 100 mM sodium pyruvate, 1% MEM 
NEAA (Gibco) and antibiotics (6.74 U/ml Penicillin-Streptomycin, 0.2 
µg/ml Fungizone) at 37 °C in humidified atmosphere containing 5% (v/v) 
CO2. Culture medium was changed twice a week, and cells used between 
passage 1 and 2 at the concentration of 5000 cells/well. For the PCR 
analysis 10000 cells/well were seeded. All reagents were from Sigma-
Aldrich, unless otherwise stated. 
 
2.5. SEM observation of cell morphology 
After seeding hMSCs in serum-free conditions on Ti surfaces, 1% (v/v) FBS 
medium was added 6 h later to guarantee cell survival and cells kept in 
culture for 3 days. When the incubation time was over, samples were 
rinsed once with PBS, to remove floating cells, and remaining cells fixed in 
2% glutaraldehyde in 0.2 M cacodylate buffer for 1 h at 4 °C. Ti disks were 
then immersed in 20, 40, 60 80 and 100% (v/v) ethanol, and 25, 50, 75 and 
100% (v/v) hexamethylsilizane in ethanol. Afterwards, Ti disks were 
mounted onto a stub and sputter coated with gold (high resolution sputter 
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coater, Agar Scientific) for analysis on a Zeiss Sigma FE-SEM microscope. 
All reagents are from Sigma-Aldrich, unless otherwise stated. 
 
2.6. Cell attachment and immunostaining 
Cells were seeded and kept in serum-free medium for 6 h. The medium 
was then replaced with 1% (v/v) FBS medium and kept in culture for 18 h. 
At harvest (24 h incubation), surfaces were rinsed with PBS, and cells fixed 
in a 10% formaldehyde solution, permeabilized, and blocked in 1% (w/v) 
BSA/PBS. hMSCs were stained with 1:150 mouse anti-vinculin and 1:500 
phalloidine-rhodamine  in 1% (w/v) BSA/PBS for 1 h at 37 °C. After rinsing 
samples 3x5 min in 0.5% (v/v) Tween‐20/PBS, 1:50 biotinylated anti-mouse 
secondary antibody (Vector Laboratories) was added in 1% (w/v) BSA/PBS 
and incubated again at 37 °C for 1 h. After washing, 1:50 FITC‐conjugated 
streptavidin (Vector Laboratories) was added and incubated for 30 min at 4 
°C. Finally, disks were washed and mounted using Vectashield mountant 
with DAPI nuclear stain (Vector Laboratories).  All reagents are from 
Sigma-Aldrich, unless otherwise stated. Images from the immunostaining 
experiments were analyzed with the Fiji/Image-J package [34]. A self-made 
macro was used to quantify DAPI-stained nuclei, while characterization of 
cell-projected area, shape and focal adhesion length was done manually.  
 
2.7. PCR analysis 
After culturing cells for 21 days on Ti disks, total RNA was extracted using 
the RNeasy micro kit (Qiagen, Hilden, Germany) according to 
manufacturer instructions. A NanoDrop spectrophotometer (Thermo 
Scientific, Waltham, MA, USA) was used to quantify total RNA. RNA was 
reverse transcribed to cDNA using the QuantiTect Reverse Transcription 
Kit (Qiagen). Real time qPCR was carried out to quantify the expression of 
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osteocalcin (OCN) and osteopontin (OPN) genes with QuantiTect SYBR 
Green RT-PCR Kit (Qiagen) on a 7500 Real-Time PCR system (Applied 
Biosystems, Foster City, CA, USA). Primer sequences are reported in table 
1. Melt curve analysis was used to validate the primer sequences for the 
genes. Gene expression was normalized to GAPDH expression, which was 
chosen as the housekeeping gene, and analyzed with the  method. 
 
 
Table 1. PCR primer sequences 
 
2.8. Bacterial culture preparation 
P. aeruginosa ATCC 27853 was grown aerobically for 16 h in 10 mL Luria -
Bertani broth (LBB) in a 37 ºC shaker incubator set at 220 rpm. The 
bacterial suspension was then diluted in LBB to OD600 0.1 and further 
incubated until mid-exponential phase was reached. At this time bacterial 
cells were harvested by centrifugation (7 min, 5000 g), washed twice in 10 
mM Tris-HCl buffer (2-amino-2-(hydroxymethyl)-1,3-propanediol, adjusted 
to pH 7 with hydrochloric acid), and suspended in Tris-HCl buffer to 
OD600 0.3 (approx. 107 cfu/mL).  
 
 
 
Target Gene Forward Sequence Reverse Sequence 
GAPDH GTCAGTGGTGGACCTGACCT ACCTGGTGCTCAGTGTAGCC 
OPN AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA 
OCN CAGCGAGGTAGTGAAGAGACC TCTGGAGTTTATTTGGGAGCAG 
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2.9. Bacterial adhesion 
The test surfaces and controls were placed into a 12-well microtiter plate 
and submerged in 2 mL of bacterial suspension. Plates were incubated for 1 
h at 37 ºC under static conditions. After incubation, surfaces were rinsed to 
remove non-adherent bacteria by passing back and forth five times in a 
Universal container containing Tris-HCl buffer, repeated three times in 
total.  
 
2.10. Live/Dead staining and fluorescence microscopy 
Following rinsing, 1 mL of Live/Dead® BacLight™ bacterial viability stain 
(Invitrogen) was applied to the surfaces (as per manufacturers’ 
instructions) and incubated in the dark for 15 min at RT. Surfaces were 
then rinsed in Tris-HCl buffer as explained above to remove excess stain. 
Surfaces were maintained in 1 mL of Tris-HCl buffer, and bacterial 
adhesion and viability was visualized by fluorescence microscopy. Image J 
software was used to calculate the number of cells with intact membranes 
(SYTO 9, green) and the number of cells with damaged membranes 
(propidium iodide, red) based on 5 images per surface. The average % kill 
was determined by (no. of damaged cells / total no. of cells) * 100. FLAT, 
FINE and COARSE with each peptide (12 total) were tested in one assay, 
which was repeated on three separate occasions using the same method 
each time. 
 
2.11. Statistical analysis 
Statistical comparisons were based on analysis of variance (ANOVA) with 
Tukey post hoc test for pairwise comparisons and non-parametric Mann-
Whitney test. Results are presented as mean + SEM.   
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3. Results 
3.1.  Surface characterization 
Two nanotopographies have been generated by applying a 
hydrothermal treatment to Ti samples for different reaction times. As 
shown in figure 2A, the length of the fibers increased with reaction time: 
the 2h treatment generates homogeneous fine spike-like structures (FINE); 
when reaction time is increased to 3h, these structures grow in length and 
merge to form much bigger pocket-like structures on the surface 
(COARSE). Geometrical features of these structures, obtained from the 
SEM image analysis, are summarized in Table 2 and the height profile is 
reported in Figure 2B.  
Figure 2. (A) SEM images of the nanotopographies. The labels tip-to-tip distance - D, 
“pocket” area - A, fiber diameter -  fD refer to the measured geometrical features of the 
nanostructure in table 2. (B) Height profile of the FINE (left) and COARSE (right) 
topographies. 
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Table 2. Geometrical features of the nanotopographies. The labels (tip-to-tip distance - D, 
“pocket” area - A, fiber diameter -  fD) refer to the highlighted features of the structures in 
figure 2A. Values are reported as mean ± SD. 
 
3.2. SEM observation of cell attachment reveals different attachment modes 
depending on the topography 
Given the completely different topography presented to cells in the 
FLAT, FINE, and COARSE conditions, a difference in the way cells attach 
and probe the substrate is expected. SEM analysis has been carried out 
after incubating cells on the Ti substrates for 3 days. As shown in figure 3, 
cells spread more on the FLAT and FINE surfaces, while they look more 
rounded on the COARSE topography. Moreover, hMSCs probe the surface 
with cytoskeletal fiber extensions both on the smooth and on the FINE 
nanotopography. These extensions look thinner, less branched and more 
numerous on the FINE substrate. On the other hand, almost no elongation 
is observed on the COARSE topography. Both on the FINE and the 
COARSE topographies cells appear to have indentations (perhaps even 
piercings) throughout their lamellae by the spike-like structures of the 
surfaces. 
Nanotopography Geometrical feature 
FINE 
D (171.3 ± 48.3) nm 
fD (34.0 ± 6.5) nm 
COARSE 
A (2.90 ± 1.80) μm2 
fD (7.78 ± 2.56) nm 
192 
 
Figure 3. SEM images of hMSCs attaching on the flat Ti and Ti nanotopographies. 
Cells interact with the nanofeatures as can be seen by retraction fiber terminations 
and membrane indentations. This effect is most notable on the COARSE 
topography. Each column of images has the same magnification.  
 
3.3. Effect of topography and ligand presentation on the number, area, 
and circularity of attached cells 
For all cellular experiments including biomolecules, cell  seeding has 
been done in serum-free conditions, in order to let cells attach to the 
surface mainly via the receptor-binding ligands, and avoiding unspecific 
interactions with serum proteins. Characterization of short-time cell 
response to the functionalized topographies was performed by incubating 
hMSCs for 24 h on the substrates and immunostaining nuclei and actin 
cytoskeleton. The number of cells attached to the FLAT and FINE Ti 
samples was not significantly affected by the presence of the synthetic 
ligands (figure 4A). Nonetheless, on the COARSE topography, where fewer 
cells adhered in the uncoated condition compared to the FLAT and FINE 
surfaces, the presence of the synthetic ligands generated an increase in cell 
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number, which was statistically significant in the case of the α5β1 -selective 
mimetic (COARSE-51) and the RGD/PHSRN platform (COARSE-P).  
Though the presence of the receptor-binding ligands only affected 
attachment on the COARSE surface, hMSC projected area was increased by 
the addition of the biomolecules on all topographies (figure 4B). On the 
FLAT surfaces, this increase was statistically significant only for the αvβ3-
selective mimetic (FLAT-V3) and the RGD/PHSRN platform (FLAT-P). 
However, on the FINE and COARSE topographies, all biomolecules 
generated a significant increase in area compared to the uncoated sample 
of the same topography. Though cells appeared smaller on FINE and 
COARSE uncoated topographies compared to FLAT, no statistically 
significant difference in cell area was observed comparing the three 
uncoated topographies (not shown). Finally, quantification of cell 
circularity reveals that hMSC shape was unaffected by the presence of the 
peptide on the FLAT surface (figure 4C), where circularity attained low 
values in all conditions. Interestingly, a different outcome was observed on 
both nanotopographies: all ligands caused a statistically significant 
decrease in cell circularity. The increase in cell area and decrease in cell 
circularity when hMCSs are incubated on biomolecule-coated FINE and 
COARSE topographies, compared to their uncoated control, was also 
evident in the immunostained actin cytoskeleton in figure 5.  
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Figure 4. Number of attached cells (A), cell projected area (B), and cell circularity (C) on 
the FLAT (first column of graphs), FINE (second column of graphs), and COARSE (third 
column of graphs) surfaces with or without biomolecule coating. Cell projected area has 
been normalized to the uncoated condition in each graph (FLAT, FINE, and COARSE, 
respectively). Number of attached cells is not affected by the biomolecules on FLAT and 
FINE, while more cells adhere to the biomolecule-coated COARSE substrates. Cell area is 
significantly increased in presence of the biomolecule on all three topographies. While 
low circularity is observed on all FLAT conditions, the biomolecule-coated FINE and 
COARSE surfaces present lower circularity compared to the respective uncoated 
topography. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 vs. uncoated condition (FLAT, 
FINE and COARSE, respectively). 
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Figure 5. Immunostained actin fibers and DAPI-stained nuclei after 24 h of 
incubation. Cell spread more on the biomolecule-coated nanotopographies, 
compared to their uncoated control. A decrease in circularity was also evident on 
the COARSE and FINE substrates presenting integrin-binding ligands. Scale bar = 
100 μm. 
Figure 6. Immunostaining of vinculin after 24 h of incubation. Fluorescence 
intensity of vinculin adhesion sites on the biomolecule-coated substrate was 
increased when compared to the uncoated controls. Scale bar = 50 μm. 
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3.4. Focal adhesion dimension is both topography and chemistry-
dependent 
hMSCs cultured for 24 h on the coated and uncoated Ti samples were 
immunostained to visualize vinculin. This protein, which is part of the 
focal adhesion complex, is commonly used to label focal adhesions (FAs). 
As shown in figure 6, vinculin staining was more intense when cells adhere 
to the functionalized surfaces, compared to when they attached to their 
uncoated counterparts. This is observed on all three topographies and it is 
particularly evident on the FINE nanotopography, where vinculin staining 
had very low intensity on the uncoated condition. By means of image 
analysis, the dimension of focal contacts was quantified (figure 7). Focal 
contact dimension appeared to be influenced by both the topography and 
the chemistry of the substrate. The effect of both nanotopographies (FINE 
and COARSE) was to produce an overall reduction in the distribution of 
FA area, compared to the FLAT surface. However, the effect of the 
biomolecules was to generate a shift towards larger focal adhesions, 
compared to the uncoated topographies. This increase in FA area is 
statistically significant on the FINE-51, COARSE-V3 and COARSE-51 
surfaces, compared to their uncoated controls (FINE and COARSE, 
respectively). 
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Figure 7. Focal adhesion area on FLAT, FINE, and COARSE topographies 
after 24 h incubation. Passing from the smooth Ti to FINE and COARSE surfaces, 
FA area was reduced. However, upon grafting biomolecules, the dimension of the 
FA was increased compared to the uncoated condition of each topography.  ** 
p<0.01 vs. uncoated condition (FLAT, FINE and COARSE, respectively). 
 
3.5. Expression of osteogenic genes  
Quantitative PCR analysis of gene expression was carried out after 21 days 
of incubation in basal medium on the uncoated and biomolecule-coated 
topographies. The expression of the late osteogenic markers OCN and OPN 
was evaluated in order to monitor the progression of hMSCs into the 
osteoblastic lineage (figure 8). The trend for expression of both genes was 
very similar on all topographies: though not statistically significant, the 
αvβ3-selective peptidomimetic stimulated the highest expression of both 
OCN and OPN on FLAT, FINE and COARSE Ti topographies, while the 
α5β1-selective peptidomimetic and the RGD/PHSRN peptidic platform did 
not change gene expression significantly on all topographies. The increase 
caused by the αvβ3-selective peptidomimetic was particularly evident on 
the COARSE topography, and it was significantly higher compared to the 
uncoated control and the other peptidic coatings in the case of OCN. No 
significant difference has been observed among topographies (not shown).  
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Figure 8. Expression of the osteogenic markers osteocalcin (A) and osteopontin (B). A 
clear trend towards higher marker expression on the αvβ3-selective peptidomimetic (V3) 
is visible, though statistically significant only on the COARSE topography. Data have 
been normalized to the uncoated condition of the respective topography. * p<0.05 vs. 
uncoated condition (FLAT, FINE and COARSE, respectively). 
 
3.6. Topography dictates bacterial attachment  
In order to check the effect of topography and ligands on the bactericidal 
properties of the surfaces, bacterial attachment (P. aeruginosa) assays were 
carried out on the substrates. Compared to the polished Ti surfaces (FLAT), 
both topographies (FINE and COARSE) presented a higher number of dead 
cells, as shown in figure 9. No effect of the grafted ligands was observed 
irrespectively of the topography of the substrate, since no variation of the 
percentage of dead cells was detected compared to the uncoated condition 
of each topography (figure 9B). 
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Figure 9. Representative fluorescence microscopy images (A) of P. aeruginosa 
stained with Live/Dead viability stain and percentage of dead cells (B). Live cells 
are stained green, while dead cells appear red. Increase in the %kill was observed 
on both nanotopographies, compared to the FLAT Ti surface. No effect of the 
biomolecules is visible. ** p<0.01 vs. uncoated condition (FLAT, FINE and 
COARSE, respectively).  
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4. Discussion 
A plethora of metallic materials have been optimized to serve as 
biomaterials for joint replacement implants [35]. Several alloys, especially 
Ti-based, have been generated to meet the structural requirements of 
orthopedic implants. Nonetheless, premature failure still occurs, mainly 
due to aseptic loosening or infection. In the quest for an optimized 
integration with the surrounding tissues and reduction of bacterial 
colonization, the focus is at the tissue-implant interface: physicochemical 
modifications can convert biocompatible inert surfaces into bioactive ones, 
which actively discourage infection and foster osseointegration [4].  
With the aim of creating a multi-functional Ti surface that is 
simultaneously osseoinductive and antibacterial, we propose merging two 
classical surface functionalization strategies, namely topographical and 
chemical modification of the surface. The hydrothermal treatment 
described in this study allows for the generation of Ti substrates with 
nanoscale, high aspect ratio topographical features and does not require 
any constraint on the shape and dimension of the sample. The rationale 
behind the generation of such topographies is the biomimesis of natural 
bactericidal surface, such as the wings of the Clanger cicada (Psaltoda 
claripennis) [10,18,19] and the dragonfly Diplacodes bipunctata [20]. To 
simultaneously enhance the cell adhesive properties of the topographies, 
which were reduced compared to the flat Ti surface, we combined the bio-
inspired substrates with low molecular weight integrin-binding molecules. 
Previous studies from our group already reported stimulation of 
osteoblast-like cell attachment, increased cell spreading and osteogenic 
differentiation, exerted by the three ligands used in the present work 
[23,29]. 
As observed in the lowest magnification SEM images, fewer hMSCs 
adhere and spread on the nanotopographies, compared to the flat polished 
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Ti surface. The fact that cells also look slightly detached from the 
nanotopographies suggests that binding to the surface is weaker, compared 
to the polished FLAT Ti surface. Similarly, immunostaining of actin 
cytoskeleton reveals that cell shape is much more circular on both the FINE 
and COARSE topographies compared to the flat surface, with the 
formation of less and smaller cytoskeletal elongations. However, adhesive 
capacity of the nanotopographies is rescued after grafting integrin-binding 
peptides: presenting receptor-binding cues on the nanowires fosters 
spreading of cells, which also present a much less circular shape. 
Interestingly, the effect of the biomolecules is much more evident on the 
less adhesive nanotopographies, than on the polished surface. hMSCs are 
more prone to attach and spread on the FLAT Ti surface, where they reach 
low values of circularity, even in absence of any ligand on the surface.  On 
the contrary, on FINE and COARSE topographies, where cell spreading is 
less fostered and cells stay mostly rounded, the presence of the integrin 
ligands is crucial. 
  Focal adhesions are also affected by the integrin-binding molecules: 
vinculin-staining is much more intense and focal adhesion area is increased 
on all surfaces, including the polished control, in presence of the ligands.  
This might be due to the exposure of integrin-binding cues on the surface, 
which stimulate the formation of bigger adhesions by recruiting cell 
surface receptors. Though few studies combined topographical stimulation 
and biochemical signals, an enhancing effect in terms of cell adhesion was 
previously observed on RGD-functionalized nanoporous alumina 
membranes [36] and sandblasted Ti6Al4V disks [32].  
Since both nanotopography and biochemical signals are known to 
ultimately alter gene expression by inducing nuclear structural changes 
and activating specific signaling cascades, hMSC differentiation was 
expected to change on our functionalized topographies. A trend towards 
higher expression of osteogenic markers (OCN and OPN) is detected on the 
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Ti surfaces coated with the αvβ3-selective peptidomimetic, though gene 
expression statistically increases only on the least-adhesive COARSE 
topography, compared to the uncoated control of this nanotopography. 
The positive effect of this integrin subtype on osteogenic differentiation of 
osteoblasts and MSCs has been previously reported [37,38]. From these 
observations, it seems that the more α5β1-selective surfaces, both the 
peptidomimetic one and the FN-inspired, are less effective in stimulating 
osteogenesis on these substrates.  Osteogenesis is known to require 
development of large, super-mature, adhesions supporting increasing 
cytoskeletal tension [15,16,39]. Integrin subtype αvβ3 is selective for 
vitronectin, which has been implicated in increased adhesion bridging 
compared to FN (which preferentially binds integrin α5β1) [40]. 
Potentially, such bridging would facilitate increased adhesion between 
topographical features [9]. 
Finally, nanotopography-related bactericidal properties of the samples 
were tested with P. aeruginosa attachment assays. Similar surfaces were 
previously reported to be bactericidal [10]. However, surfaces were not 
tested in presence of biomolecules. As expected, both FINE and COARSE 
nanotopographies were more effective than flat Ti in inducing bacteria 
death due to the mechanical effect of their high aspect ratio nanofeatures. 
Coating of the substrates with the integrin-binding ligands did not affect 
the bactericidal properties of the nanostructured substrates, thereby 
indicating that such antibacterial effect is merely caused by the topography 
of the surface, rather than by biochemical signals. This mechanical 
bactericidal effect has been observed before on artificial surfaces 
presenting similar bio-inspired nanotopography [20]. 
 
 
 
203 
 
5. Conclusions 
The design of multifunctional coatings has increasing relevance, 
especially to solve multiple issues, such as infection and impaired 
osseointegration of joint-replacement implants. In this work, we proposed 
merging topographical and biochemical cues on the surface of a clinically 
relevant material such as Ti. Compared to other methods, the bactericidal 
effect given by the topography is particularly interesting for application in 
the orthopedic field as it circumvents the problems associated with the 
systemic release of antibacterial agents. By grafting cell receptor-binding 
ligands on nanotopographies, we could simultaneously take advantage of 
the topography-induced inhibition of bacteria colonization and improve 
the adhesive properties of the nanostructured substrates. While integrin-
binding molecules did not affect antibacterial properties of the 
nanotopographies, they fostered cell attachment, spreading, focal contacts 
formation and, in some cases, differentiation of hMSCs on Ti. This study 
offers an example of how combination of very different strategies can be a 
straightforward method to obtain multifunctional biomaterial surfaces.  
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